Document_And_Entity_Informatio
Document And Entity Information | 3 Months Ended | |
Sep. 30, 2014 | Nov. 14, 2014 | |
Document Information [Line Items] | ' | ' |
Document Type | '10-Q | ' |
Amendment Flag | 'false | ' |
Document Period End Date | 30-Sep-14 | ' |
Document Fiscal Year Focus | '2015 | ' |
Document Fiscal Period Focus | 'Q1 | ' |
Entity Registrant Name | 'Flux Power Holdings, Inc. | ' |
Entity Central Index Key | '0001083743 | ' |
Current Fiscal Year End Date | '--06-30 | ' |
Entity Filer Category | 'Smaller Reporting Company | ' |
Trading Symbol | 'FLUX | ' |
Entity Common Stock, Shares Outstanding | ' | 96,947,446 |
CONDENSED_CONSOLIDATED_BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) | Sep. 30, 2014 | Jun. 30, 2014 |
Current assets: | ' | ' |
Cash | $58,000 | $116,000 |
Accounts receivable, net | 37,000 | 140,000 |
Inventories, net | 102,000 | 85,000 |
Other current assets | 39,000 | 18,000 |
Total current assets | 236,000 | 359,000 |
Other assets | 27,000 | 25,000 |
Property, plant and equipment, net | 74,000 | 78,000 |
Total assets | 337,000 | 462,000 |
Current liabilities: | ' | ' |
Accounts payable | 443,000 | 320,000 |
Accrued expenses | 222,000 | 219,000 |
Customer deposits from related party | 136,000 | 136,000 |
Warrant derivative liability | 133,000 | 571,000 |
Total current liabilities | 934,000 | 1,246,000 |
Long term liabilities: | ' | ' |
Related party note payable | 25,000 | 0 |
Line of credit, net of discount | 20,000 | 0 |
Total liabilities | 979,000 | 1,246,000 |
Commitments and contingencies (Note 5) | ' | ' |
STOCKHOLDERS' DEFICIT | ' | ' |
Preferred stock, $0.001 par value: authorized 5,000,000 shares, none issued and outstanding | 0 | 0 |
Common stock, $0.001 par value: authorized 145,000,000 shares, 94,857,444 and 93,274,113 shares issued and outstanding as of September 30, 2014 and June 30, 2014, respectively | 95,000 | 93,000 |
Additional paid-in capital | 7,736,000 | 7,399,000 |
Accumulated deficit | -8,473,000 | -8,276,000 |
Total stockholders' deficit | -642,000 | -784,000 |
Total liabilities and stockholders' deficit | $337,000 | $462,000 |
CONDENSED_CONSOLIDATED_BALANCE1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Sep. 30, 2014 | Jun. 30, 2014 |
Preferred stock, par value | $0.00 | $0.00 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, issued | 0 | 0 |
Preferred stock, outstanding | 0 | 0 |
Common stock, par value | $0.00 | $0.00 |
Common stock, shares authorized | 145,000,000 | 145,000,000 |
Common stock, issued | 94,857,444 | 93,274,113 |
Common stock, outstanding | 94,857,444 | 93,274,113 |
CONDENDED_CONSOLIDATED_STATEME
CONDENDED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | |||
Sep. 30, 2014 | Sep. 30, 2013 | |||
Net revenue | $86,000 | [1] | $34,000 | [1] |
Cost of revenue | 79,000 | 21,000 | ||
Gross profit | 7,000 | 13,000 | ||
Operating expenses: | ' | ' | ||
Selling and administrative expenses | 507,000 | 269,000 | ||
Amortization of prepaid advisory fees | 0 | 411,000 | ||
Research and development | 121,000 | 107,000 | ||
Total operating expense | 628,000 | 787,000 | ||
Operating loss | -621,000 | -774,000 | ||
Other income (expense): | ' | ' | ||
Change in fair value of warrant derivative liability | 438,000 | 81,000 | ||
Interest expense, net | -14,000 | -53,000 | ||
Net loss | ($197,000) | ($746,000) | ||
Net loss per common share - basic and diluted | $0 | ($0.02) | ||
Weighted average number of common shares outstanding - basic and diluted | 93,857,083 | 47,493,619 | ||
[1] | Includes sales to related parties of approximately $0 and $3,000 for the three months ended September 30, 2014 and 2013, respectively. |
CONDENDED_CONSOLIDATED_STATEME1
CONDENDED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) (USD $) | 3 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Related Parties Amount in Cost of Sales | $0 | $3,000 |
CONDENSED_CONSOLIDATED_STATEME
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 3 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Cash flows from operating activities: | ' | ' |
Net loss | ($197,000) | ($746,000) |
Adjustments to reconcile net loss to net cash used in operating activities: | ' | ' |
Depreciation | 10,000 | 12,000 |
Amortization of prepaid advisory fees | 0 | 411,000 |
Change in fair value of warrant liability | -438,000 | -81,000 |
Stock-based compensation | 51,000 | 23,000 |
Stock issued for services | 0 | 20,000 |
Changes in operating assets and liabilities: | ' | ' |
Accounts receivable | 103,000 | 5,000 |
Inventories | -17,000 | -3,000 |
Other current assets | -20,000 | 57,000 |
Accounts payable | 123,000 | 12,000 |
Accrued expenses | 79,000 | -108,000 |
Accrued interest | 0 | 52,000 |
Customer deposits | 0 | 14,000 |
Customer deposits from related party | 0 | -2,000 |
Net cash used in operating activities | -306,000 | -334,000 |
Cash flows from investing activities: | ' | ' |
Purchases of equipment | -6,000 | 0 |
Net cash used in investing activities | -6,000 | 0 |
Cash flows from financing activities: | ' | ' |
Net proceeds from the sale of common stock and warrants, net of offering costs paid | 129,000 | 0 |
Proceeds from related party note payable and line of credit | 125,000 | 363,000 |
Net cash provided by financing activities | 254,000 | 363,000 |
Net (decrease) increase in cash | -58,000 | 29,000 |
Cash, beginning of period | 116,000 | 20,000 |
Cash, end of period | 58,000 | 49,000 |
Supplemental disclosures of Non-cash Financing Activities: | ' | ' |
Issuance of warrants recorded as deferred financing costs | 3,000 | 0 |
Debt discount related to warrants and beneficial conversion feature | $80,000 | $0 |
BASIS_OF_PRESENTATION_AND_NATU
BASIS OF PRESENTATION AND NATURE OF BUSINESS | 3 Months Ended |
Sep. 30, 2014 | |
Organization, Consolidation and Presentation Of Financial Statements [Abstract] | ' |
BASIS OF PRESENTATION AND NATURE OF BUSINESS | ' |
NOTE 1 – BASIS OF PRESENTATION AND NATURE OF BUSINESS | |
Basis of Presentation | |
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014 filed with the SEC. In the opinion of management, the accompanying condensed consolidated interim financial statements include all adjustments, necessary in order to make the financial statements not misleading. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year or any other future period. Certain notes to the financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal year as reported in the Company’s Annual Report on Form 10-K have been omitted. The accompanying condensed consolidated balance sheet at June 30, 2014 has been derived from the audited balance sheet at June 30, 2014 contained in such Form 10-K. | |
The accompanying condensed consolidated financial statements of the Company have been prepared on a going-concern basis. See Note 2 for discussion of liquidity/going concern matters. | |
Nature of Business | |
Flux Power Holdings, Inc. (“Flux” or the “Company”) was incorporated as Olerama, Inc. in Nevada in 1998. Since its incorporation, there have been several name changes, including the change in January 2010 whereby the name of the Company was changed to Lone Pine Holdings, Inc. Following the completion of a reverse merger on June 14, 2012, as described below, the Company’s operations have been conducted through its wholly owned subsidiary, Flux Power, Inc. (“Flux Power”), a California corporation. | |
On May 23, 2012, by way of a merger, Lone Pine Holdings changed its name to Flux Power Holdings, Inc. (“FPH”) a Nevada corporation. The transaction has been reflected as a reverse merger where FPH was the surviving legal entity after the merger. Flux Power remained the accounting acquirer. The merger has been accounted for as a recapitalization as of the earliest period presented. Accordingly, the historical condensed consolidated financial statements represented are those of Flux Power. | |
Flux Power develops and sells rechargeable advanced energy storage systems. The Company has structured its business around its core technology, “The Battery Management System” (“BMS”). The Company’s BMS provides three critical functions to their battery systems: cell balancing, monitoring and error reporting. Using its proprietary management technology, the Company is able to offer complete integrated energy storage solutions or custom modular standalone systems to their clients. The Company has also developed a suite of complementary technologies and products that accompany their core products. Sales during the three months ended September 30, 2014 and 2013 were primarily to customers located throughout the United States. | |
As used herein, the terms “we,” “us,” “our,” and “Company” mean Flux Power Holdings, Inc., unless otherwise indicated. All dollar amounts herein are in U.S. dollars unless otherwise stated. | |
LIQUIDITY_AND_GOING_CONCERN
LIQUIDITY AND GOING CONCERN | 3 Months Ended |
Sep. 30, 2014 | |
Liquiditiy And Going Concern [Abstract] | ' |
LIQUIDITY AND GOING CONCERN | ' |
NOTE 2 – LIQUIDITY AND GOING CONCERN | |
The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred an accumulated deficit of $8,473,000 through September 30, 2014, and as of September 30, 2014 had limited cash and a working capital deficit. To date, the Company’s revenues and operating cash flows have not been sufficient to sustain its operations and it has relied on debt and equity financing to fund its operations. Management estimates that additional capital of approximately $1.6 million is required to fund planned operations through June 30, 2015. These factors raise substantial doubt about the Company’s ability to continue as a going concern. | |
The Company’s ability to continue as a going concern is dependent upon our ability to raise additional capital on a timely basis until such time as revenues and related cash flows are sufficient to fund our operations. | |
Management plans to continue to seek funding, as necessary, through private placements of equity securities. The Company initiated a private placement in August 2014 to raise $990,000. A total of $322,500 has been raised as of November 14, 2014. In addition, the Company is pursuing other investment structures that management believes may generate the necessary funding for the Company. Although management believes that the additional required funding will be obtained, there is no guarantee the Company will be able to obtain the additional required funds on a timely basis or that funds will be available on terms acceptable to the Company. If such funds are not available when required, management will be required to curtail its investments in additional sales and marketing and product development resources, and capital expenditures, which may have a material adverse effect on the Company’s future cash flows and results of operations, and its ability to continue operating as a going concern. The accompanying financial statements do not include any adjustments that would be necessary should the Company be unable to continue as a going concern and, therefore, be required to liquidate its assets and discharge its liabilities in other than the normal course of business and at amounts that may differ from those reflected in the accompanying condensed consolidated financial statements. | |
SUMMARY_OF_SIGNIFICANT_ACCOUNT
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Sep. 30, 2014 | |
Accounting Policies [Abstract] | ' |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ' |
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
A summary of the Company’s significant accounting policies consistently applied in the preparation of the accompanying condensed consolidated financial statements follows: | |
Basis of Consolidation | |
The condensed consolidated financial statements include the Flux Power Holdings, Inc. and its wholly-owned subsidiary Flux Power Inc. after elimination of all intercompany accounts and transactions. | |
Subsequent Events | |
Management has evaluated events subsequent to September 30, 2014 through the date filed with the Securities and Exchange Commission for transactions and other events that may require adjustment of and/or disclosure in such financial statements. | |
Reclassifications | |
Certain prior year amounts have been reclassified to conform to the current year presentation for comparative purposes. | |
Use of Estimates in Financial Statement Preparation | |
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as certain financial statement disclosures. Significant estimates include valuations of equity instruments and deferred tax assets. While management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from these estimates. | |
Cash and Cash Equivalents | |
As of September 30, 2014, cash totaled approximately $58,000 and consists of funds held in a non-interest bearing bank deposit account. The Company considers all highly liquid short term investments with maturities of less than three months when acquired to be cash equivalents. The Company had no other cash equivalents at September 30, 2014 and June 30, 2014. | |
Fair Values of Financial Instruments | |
The carrying amount of our accounts payable and accounts receivable approximates their estimated fair values due to the short-term maturities of those financial instruments. The carrying amount of notes payable and line of credit approximates their fair value as the interest approximates current market interest rates for the similar instruments. Derivative liabilities recorded in connection with warrants are reported at their estimated fair value, with changes in fair value being reported in results of operations (see Note 8). Except for derivative liabilities referenced above, the Company does not have any other assets or liabilities that are measured at fair value on a nonrecurring basis. | |
Accounts Receivable and Customer Deposits | |
Accounts receivable are carried at their estimated collectible amounts. The Company may require advance deposits from its customers prior to shipment of the ordered products. The Company has not experienced collection issues related to its accounts receivable, and has not recorded an allowance for doubtful accounts at either September 30, 2014 or June 30, 2014. | |
Inventories | |
Inventories consist primarily of battery management systems and the related subcomponents, and are stated at the lower of cost (first-in, first-out) or market. The Company evaluates inventories to determine if write-downs are necessary due to obsolescence or if the inventory levels are in excess of anticipated demand at market value based on consideration of historical sales and product development plans. The Company did not record an adjustment related to obsolete inventory at either September 30, 2014 or June 30, 2014. | |
Property, Plant and Equipment | |
Property, plant and equipment are stated at cost, net of accumulated depreciation. Depreciation and amortization are provided using the straight-line method over the estimated useful lives, of the related assets ranging from three to ten years, or, in the case of leasehold improvements, over the lesser of the useful life of the related asset or the lease term. | |
Stock-based Compensation | |
Pursuant to the provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718-10, Compensation–Stock Compensation, which establishes accounting for equity instruments exchanged for employee service, we utilize the Black-Scholes option pricing model to estimate the fair value of employee stock option awards at the date of grant. This model, which requires the input of highly subjective assumptions, includes expected volatility and expected life of the options. Changes in these inputs and assumptions can materially affect the measure of estimated fair value of our share-based compensation. These assumptions are subjective and generally require significant analysis and judgment to develop. When estimating fair value, some of the assumptions will be based on, or determined from, external data and other assumptions may be derived from our historical experience with stock-based payment arrangements. The appropriate weight to place on historical experience is a matter of judgment, based on relevant facts and circumstances. In accordance with this guidance, the estimated grant-date fair value of options expected to vest is recognized as compensation expense on a pro-rata basis over the vesting period of the options. | |
Common stock or equity instruments such as warrants issued for services to non-employees are valued at their estimated fair value at the measurement date (the date when a firm commitment for performance of the services is reached, typically the date of issuance, or when performance is complete). | |
Revenue Recognition | |
The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred, price is fixed or determinable, and collectability of the selling price is reasonably assured. Delivery occurs when risk of loss is passed to the customer, as specified by the terms of the applicable customer agreements. When a right of return exists, contractually or implied, the Company recognizes revenue on the sell-through method. Under this method, revenue is not recognized upon delivery of the inventory components. Instead, the Company records deferred revenue upon delivery and recognize revenue when the inventory components are sold through to the end user. During the three months ended September 30, 2014 and 2013, the Company did not record any deferred revenue. | |
Sales Returns and Allowances | |
The Company evaluates its exposure to sales returns and allowances based on historical experience. The Company has not experienced returns during the three months ended September 30, 2014 and 2013, and accordingly, the Company did not record sales returns and allowance. | |
Product Warranties | |
The Company evaluates its exposure to product warranty obligations based on historical experience. Our products are warrantied for five years unless modified by a separate agreement. As of September 30, 2014 and June 30, 2014, the Company recorded warranty liability of approximately $12,000, which was included in accrued expenses on the Company’s balance sheet. | |
Shipping and Handling Costs | |
The Company records shipping and handling costs charged to customers as revenue and shipping and handling costs to cost of sales as incurred. | |
Impairment of Long-lived Assets | |
In accordance with authoritative guidance for the impairment or disposal of long-lived assets, if indicators of impairment exist, the Company assesses the recoverability of the affected long-lived assets by determining whether the carrying value of such assets can be recovered through the undiscounted future operating cash flows. | |
If impairment is indicated, the Company measures the amount of such impairment by comparing the carrying value of the asset to the present value of the expected future cash flows associated with the use of the asset. The Company believes that no impairment indicators are present. | |
Research and Development | |
The Company is actively engaged in new product development efforts. Research and development cost relating to possible future products are expensed as incurred. | |
Income Taxes | |
The Company follows FASB ASC Topic No. 740, Income Taxes. Deferred tax assets or liabilities are recorded to reflect the future tax consequences of temporary differences between the financial reporting basis of assets and liabilities and their tax basis at each year-end. These amounts are adjusted, as appropriate, to reflect enacted changes in tax rates expected to be in effect when the temporary differences reverse. | |
The Company records deferred tax assets and liabilities based on the differences between the financial statement and tax bases of assets and liabilities and on operating loss carry forwards using enacted tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. | |
We also follow the provisions of FASB ASC Topic No.740 relating to uncertain tax provisions and have analyzed filing positions in all of the federal and state jurisdictions where the Company is required to file income tax returns, as well as all open tax years in these jurisdictions. Based on our analysis, no unrecognized tax benefits have been identified as of September 30, 2014 or June 30, 2014, and accordingly, no additional tax liabilities have been recorded. | |
Net Income (Loss) Per Common Share | |
The Company calculates basic income (loss) per common share by dividing net earnings or loss by the weighted average number of common shares outstanding during the periods. Diluted earnings (loss) per common share include the impact from all dilutive potential common shares relating to outstanding convertible securities. | |
For the three months, ended September 30, 2014, basic and diluted weighted-average common shares outstanding were 93,857,083. The Company incurred a net loss for the three months ended September 30, 2014, and therefore, basic and diluted loss per share for those periods are the same because the inclusion of potential common equivalent shares were excluded from diluted weighted-average common shares outstanding during the period, as the inclusion of such shares would be anti-dilutive. As of September 30, 2014, there were 2,625,992 potentially dilutive common shares outstanding, which include common shares underlying outstanding stock options and warrants that were excluded from diluted weighted-average common shares outstanding. | |
For the three months, ended September 30, 2013, basic and diluted weighted-average common shares outstanding were 47,493,619. The Company incurred a net loss for the three months ended September 30, 2013, and therefore, basic and diluted loss per share for those periods are the same because the inclusion of potential common equivalent shares were excluded from diluted weighted-average common shares outstanding during the period, as the inclusion of such shares would be anti-dilutive. As of September 30, 2013, there were 808,662 potentially dilutive common shares outstanding, which include common shares underlying outstanding stock options and warrants that were excluded from diluted weighted-average common shares outstanding. | |
Derivative Financial Instruments | |
The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. | |
We evaluate free-standing derivative instruments (or embedded derivatives) to properly classify such instruments within equity or as liabilities in our financial statements. The classification of a derivative instrument is reassessed at each reporting date. If the classification changes because of events during a reporting period, the instrument is reclassified as of the date of the event that caused the reclassification. There is no limit on the number of times a contract may be reclassified. | |
Instruments classified as derivative liabilities are recorded initially at their estimated fair value and are re-measured each reporting period (or upon reclassification) and the change in fair value is recorded on our condensed consolidated statements of operations in other (income) expense. | |
The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic No. 815, Derivatives and Hedging to classify and value warrant liabilities. Warrants classified as derivative liabilities are recorded at their fair values at the issuance date and are revalued at each subsequent reporting date, using a Monte Carlo simulation (“MCS”). A MCS model uses a simulation technique to generate multiple random price paths for the stock price to simulate many possible future outcomes, which are then discounted at the risk-free rate. These simulated paths are then averaged to determine the fair value of the warrants (see Note 7). | |
New Accounting Standards | |
In August 2014, The FASB issued Accounting Standards Update (ASU) No. 2014-15 regarding ASC topic No. 205, Presentation of Financial Statements – Going Concern. The standard requires all companies to evaluate if conditions or events raise substantial doubt about an entity’s ability to continue as a going concern and requires different disclosure of items that raise substantial doubt bit are, or are not, alleviated as a result of consideration of management’s plans. ASU 2014-15 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2016. Early adoption is permitted. We are currently evaluating the impact this guidance will have on our consolidated financial statements. | |
RELATED_PARTY_NOTES_PAYABLE_AN
RELATED PARTY NOTES PAYABLE AND LINE OF CREDIT | 3 Months Ended |
Sep. 30, 2014 | |
Debt Disclosure [Abstract] | ' |
RELATED PARTY NOTES PAYABLE AND LINE OF CREDIT | ' |
NOTE 4 - RELATED PARTY NOTES PAYABLE AND LINE OF CREDIT | |
In October 2011, we entered into a revolving promissory note agreement (“Revolving Note”) for $1,000,000 with Esenjay Investments, LLC (“Esenjay”), which is one of our major stockholders who beneficially own approximately 47 % of our common stock. Mr. Michael Johnson is a current member of our board of directors and is the director and sole shareholder of Esenjay. The Revolving Note had an interest rate of 8% per annum, and an original maturity date of September 30, 2013, as amended, and borrowings under this line are secured by substantially all of the assets of the Company. As of September 30, 2013, the balance outstanding payable on the note was $1,000,000. On October 16, 2013, we entered into the Second Amendment to the Revolving Note pursuant to which the Revolving Note was amended to: (i) extend the maturity date from September 30, 2013, to December 31, 2015; (ii) change the interest rate on the outstanding principal amount as of October 16, 2013, and forward to 6% per annum, and (iii) grant the holder of the Revolving Note the option to convert any or all of the amount outstanding under the Revolving Note, as amended, into shares of our common stock at a conversion price of $ 0.30 per share until December 31, 2015. | |
On March 7, 2012, we entered into an additional note payable agreement with Esenjay for $250,000 (“Bridge Note”). The Bridge Note had an original maturity date of March 7, 2014, and bore interest at the rate of 8% per annum. As of September 30, 2013, the balance outstanding payable on the Bridge Note was $250,000 and there were no further funds available under the Bridge Note. On October 16, 2013, we entered into the First Amendment to the Bridge Loan Promissory Note (the “Amendment”) pursuant to which the Bridge Note was amended to: (i) extend the maturity date from March 7, 2014, to December 31, 2015; (ii) change the interest rate on the outstanding principal amount as of October 16, 2013, and forward to 6% per annum; and (iii) grant the holder of the Bridge Note the option to convert any or all of the amount outstanding under the Bridge Note, as amended, into shares of our common stock at a conversion price of $0.30 per share until December 31, 2015. As of September 30, 2014, the remaining principal balance on the Bridge Note was $25,000. | |
On September 24, 2012, we entered into a Line of Credit agreement with Esenjay for $1,500,000 (“Line of Credit”). Borrowings under the Line of Credit are secured by our assets and bore interest at the rate of 8% per annum, with all unpaid principal and accrued interest due and payable on September 24, 2014. On October 16, 2013, we entered into the First Amendment to the Line of Credit (the “Amendment”) pursuant to which the Line of Credit was amended to: (i) extend the maturity date from September 24, 2014, to December 31, 2015; (ii) change the interest rate on the outstanding principal amount as of October 16, 2013, and forward to 6% per annum; (iii) increase the Line of Credit to $2,000,000; and (iv) grant holder the option to convert up to $400,000 of the outstanding amount under the Line of Credit into shares of our common stock at a conversion price of $0.06 per share until December 31, 2013, and the option to convert any or all of the remaining amount outstanding under the Line of Credit into shares of our common stock at a conversion price of $ 0.30 per share until December 31, 2015. | |
On January 13, 2014, we accepted a subscription agreement from Esenjay pursuant to which we sold Esenjay 10 Units for an aggregate purchase price of $600,000, or $60,000 per Unit, of which (i) $200,000 was paid in cash, and (ii) $400,000 was a conversion of $400,000 of principal amount outstanding under the Revolving Note, as amended. Each Unit consisted of 1,000,000 shares of our common stock and 500,000 warrants. In connection with Esenjay’s purchase of the Units, we issued 10,000,000 shares of our common stock and warrants to purchase up to 5,000,000 shares of our common stock, at an exercise price of $0.20 per share until January 13, 2019. | |
On March 12, 2014, we accepted a subscription agreement from Esenjay pursuant to which we sold Esenjay 2.5 Units for an aggregate purchase price of $150,000, or $60,000 per Unit, which was a conversion of $150,000 of principal amount outstanding under the Revolving Note, as amended. Each Unit consisted of 1,000,000 shares of our common stock and 500,000 warrants. In connection with Esenjay’s purchase of the Units, we issued 2,500,000 shares of our common stock and warrants to purchase up to 1,250,000 shares of our common stock, at an exercise price of $0.20 per share until March 12, 2019. On June 11, 2014, the Company converted all $2,586,000 of principal and $304,000 of accrued interest related to the Revolving Note, Bridge Note and Line of Credit, into common stock and warrants, eliminating all of Flux’s long-term debt. Flux Power’s largest shareholder, Esenjay Investments LLC, converted all of its long-term debt and accrued interest into 12.1 million shares of Flux Power restricted common stock at a price of $0.24 per share. Esenjay was also granted 3-year warrants to purchase 1.9 million shares of common stock at $0.30 per share, in connection with this conversion. | |
During fiscal 2014, a total of $3,136,000 of debt principal was converted to equity, which resulted in an ending balance of $0 for the Revolving Note, Bridge Note and Line of Credit at June 30, 2014. The exchange was accounted for as a capital transaction in accordance with ASC Topic No. 470-50-40, “Debt, Modifications and Extinguishments”. Accordingly, no gain or loss was recognized. | |
On August 21, 2014, we borrowed $25,000 under our Bridge Loan Note with Esenjay. This takedown represents our only outstanding debt under our three credit lines as of September 30, 2014. Total unused credit under these debt instruments was $3,225,000 at September 30, 2014. Esenjay has no obligation to loan funds and the right to not advance funds under these facilities. For the takedown, the interest rate is 6% and the note matures December 31, 2015. | |
On October 2, 2014, the Company entered in a line of credit agreement in the maximum amount of $500,000 (“Second Line of Credit”) with Leon Frenkel (“Lender”). The Lender had advanced funds totaling $50,000 on September 19, 2014 and $50,000 on September 30, 2014, in anticipation of signing the Second Line of Credit on October 2, 2014. Borrowings under the Second Line of Credit bears interest at 8% per annum, with all unpaid principal and accrued interest due and payable on September 19, 2016 pursuant to the terms of the Secured Convertible Promissory Note (the “Note”). In addition, at the election of Lender, all or any portion of the outstanding principal, accrued but unpaid interest and/or late charges under the S econd Line of Credit may be converted into shares of the Company’s common stock at any time at a conversion price of $0.12 per share. Borrowings under the Second Line of Credit are guaranteed by the Company and its wholly owned subsidiary, and are secured by all of the assets of the Company pursuant to the terms of a certain Security Agreement and Guaranty Agreement dated as of October 2, 2014. Proceeds from the Second Line of Credit can be solely used for working capital purposes. As of September 30, 2014, the Company borrowed a total of $100,000 under the Second Line of Credit. As of November 14, 2014, the Company has borrowed approximately $190,000 under the Second Line of Credit. In connection with the Second Line of Credit, Lender is entitled to purchase a certain number of shares of common stock of the Company equal to the outstanding advances under the Second Line of Credit divided by the conversion price of $0.12, for a term of five years, at an exercise price per share equal to $0.20. Accordingly, in connection with the advance of $190,000, Lender will be issued a warrant, pursuant to which he may exercise into 1,583,333 shares of common stock at $0.20 per share. The Lender has no other material relationship with the Company or its affiliates. The estimated relative fair value of warrants issued in connection with advances under the Second Line of Credit is recorded as a debt discount and is amortized as additional interest expense over the term of the underlying debt. In connection with advances under the Second Line of Credit through September 30, 2014 the Company issued 833,333 warrants to Lender and recorded debt discount of approximately $40,000 based on the relative fair value of these warrants. In addition, as the effective conversion price of the debt was less than the market price of the underlying common stock on the date of issuance, the Company recorded additional debt discount of approximately $40,000 related to the beneficial conversion feature. As of September 30, 2014, the $100,000 principal amount outstanding under this agreement is presented net of unamortized debt discount totaling $80,000. | |
COMMITMENTS_AND_CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Sep. 30, 2014 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
COMMITMENTS AND CONTINGENCIES | ' |
NOTE 5 – COMMITMENTS AND CONTINGENCIES | |
From time to time, we may be involved in litigation relating to claims arising out of our operations. As of September 30, 2014, we are not a party to any legal proceedings that are expected, individually or in the aggregate, to have a material adverse effect on our business, financial condition or operating results. | |
STOCKHOLDERS_EQUITY
STOCKHOLDERS' EQUITY | 3 Months Ended | ||||||||||
Sep. 30, 2014 | |||||||||||
Stockholders' Equity Note [Abstract] | ' | ||||||||||
STOCKHOLDERS' EQUITY | ' | ||||||||||
NOTE 6 - STOCKHOLDERS’ EQUITY | |||||||||||
At September 30, 2014, the Company had 145,000,000 shares of common stock, par value of $0.001 authorized for issuance. | |||||||||||
In addition, at September 30, 2014 the Company is authorized to issue up to 5,000,000 shares of preferred stock, par value of $0.001 in one or more classes or series within a class pursuant to our Articles of Incorporation. There are currently no shares of preferred stock issued and outstanding. | |||||||||||
Holders of common stock are entitled to receive dividends, when, as, and if declared by the Board of Directors, out of any assets legally available to the Company. Dividends are declared and paid in an equal per-share amount on the outstanding shares of each series of common stock. To date the Board of Directors has neither declared nor paid common stock dividends to shareholders. | |||||||||||
Common Stock and Warrants | |||||||||||
Private Placements – Fiscal 2015 | |||||||||||
On July 31, 2014, the board approved a second round of financing for calendar year 2014. As such, starting in August 2014, the Company has been conducting a Private Placement Offering of Units (“September Offering”) that is intended to raise a total of $990,000. As of September 30, 2014, we have sold 1.58 units to 9 accredited investors (“Investors”) for total gross proceeds of $142,500, pursuant to which we issued 1,583,333 shares of common stock and warrants to purchase up to 791,667 shares of common stock. The warrants are exercisable for three years and each warrant entitles the holder to purchase one share of common stock at $0.25 per share. The units were offered only to accredited investors and the purchase price of each unit was $90,000, with each unit consisting of 1,000,000 shares of common stock and 500,000 warrants. Security Research Associates, Inc. (“SRA”) served as our placement agent. SRA earned a cash commission of $12,825 based on 9% of gross proceeds and was issued a warrant to purchase 142,500 shares of our common stock at an exercise price of $0.09 for its services as our private placement agent. The cash commission of $12,825 and the estimated fair value of these warrants of approximately $10,300, was recorded as a cost of equity financing. The securities offered and sold have not been registered under the Securities Act. The securities were offered and sold in reliance upon exemptions from registration pursuant to Rule 506 promulgated thereunders. | |||||||||||
Private Placements – Fiscal 2014 | |||||||||||
From January to March 2014, the Company conducted a Private Placement Offering of Units (“March Offering”). The Units were offered only to accredited investors and the purchase price of each Unit was $60,000, with each Unit consisting of 1,000,000 shares of common stock and 500,000 warrants. The warrants are exercisable for 5 years and each warrant entitles the holder to purchase one share of common stock at an exercise price of $0.20 per share. On March 12, 2014, the Company completed the March Offering by selling an aggregate of 32.4 Units to 41 accredited investors resulting in the conversion of debt to equity in the amount of $550,000 and cash proceeds of approximately $1,394,000, and issuance of 32,400,000 shares of common stock and warrants to purchase up to 16,200,000 shares of common stock. The March Offering was conducted in three tranches. On January 13, 2014, we completed our first tranche of the March Offering by selling 10 Units to Esenjay for an aggregate purchase price of $600,000, of which (i) $200,000 was paid in cash, and (ii) $400,000 was a conversion of $400,000 of principal amount outstanding under the Revolving Note, as amended (see Note 4). In connection with Esenjay’s purchase of the Units, we issued 10,000,000 shares of our common stock and warrants to purchase up to 5,000,000 shares of our common stock. On February 14, 2014, we completed our second tranche of the March Offering by selling 2.8 Units to five accredited investors for an aggregate purchase price of $168,000, all of which were paid in cash. In connection with the closing of the second tranche, we issued a total of 2,800,000 shares of our common stock and warrants to purchase up to 1,400,000 shares of our common stock. On March 12, 2014, we completed the final tranche, to a cumulative total of 41 accredited investors, of the March Offering by closing on the sale of 19.6 Units for total purchase price of $1,176,000, pursuant to which we issued 19,600,000 shares of common stock and warrants to purchase up to 9,800,000 shares of common stock. Esenjay participated in the final tranche by purchasing a total of 2.5 Units for an aggregate purchase price of $150,000, of which the $150,000 was a conversion of principal amount outstanding under the Revolving Note, as amended (see Note 4). | |||||||||||
On June 11, 2014, the Company converted all $2,586,000 of outstanding principal and $304,000 of accrued interest related to the Revolving Note, Bridge Note and Line of Credit, into common stock and warrants, eliminating all of Flux’s long-term debt. Flux Power’s largest shareholder, Esenjay Investments LLC, converted all of its long-term debt and accrued interest into 12.1 million shares of Flux Power restricted common stock at a price of $0.24 per share. Esenjay was also granted 3-year warrants to purchase 1.9 million shares of common stock at $0.30 per share, as an incentive for the conversion. | |||||||||||
All of the above mentioned debt conversions have been accounted for as a capital transaction in accordance with FASB ASC Topic No. 470-50-40, “ Debt, Modifications and Extinguishments ”. Accordingly, no gain or loss has been recognized. | |||||||||||
Security Research Associates Inc. (“SRA”) of San Francisco served as Company’s placement agent in connection with the March Offering. The Company engaged SRA for services rendered in conjunction with this March Offering and paid cash compensation in the amount of 9% of the gross proceeds raised and a warrant to purchase the number of shares of common stock equal to 9% of the aggregate gross proceeds from the March Offering received by the Company from all investors placed by SRA divided by $0.06 per share. The Company paid SRA $107,460 and issued a warrant to purchase 1,791,000 shares of our common stock at an exercise price of $0.06 for its services as the Company’s private placement agent in the March Offering. The newly appointed director and executive chairman of the Board of Directors, Timothy Collins, is the Chief Executive Officer, President, director and shareholder of SRA. | |||||||||||
In connection with the March Offering, the Company inadvertently in error issued duplicate stock certificates representing an aggregate of 600,000 shares of common stock of the Company. As a result, there was an additional 600,000 shares of common stock issued and outstanding on the records of the Company’s transfer agent as of June 30, 2014. The Company has already corrected this error. The number of shares of common stock issued and outstanding reflected in the financial statements and these notes exclude 600,000 shares of common stock which were inadvertently issued in error. All such common share certificates have been returned as of July 2014. | |||||||||||
The securities offered and sold in the Offering have not been registered under the Securities Act of 1933, as amended (“Securities Act”). The Securities were offered and sold to accredited investors in reliance upon exemptions from registration pursuant to Rule 506 promulgated thereunder. | |||||||||||
Private Placements – Fiscal 2013 and Fiscal 2012 | |||||||||||
During fiscal years 2012 and 2013, the Company issued 5,347,839 shares of common stock and 1,069,570 five year warrants to purchase shares of our common stock at an exercise price of $0.41 per share, resulting in aggregate proceeds of approximately $2,215,000, pursuant to private placement transactions. Tranches of these transactions closed during each month during June through August of 2012 and a final tranche in October of 2012. | |||||||||||
Repricing of Warrants | |||||||||||
The fiscal year 2013 and fiscal year 2012 offering (see above) included warrants issued at a price of $0.20, which triggered an anti-dilution protection for Company’s warrant holders issued under our 2012 Private Placements that were issued for an offering price of our common stock at $0.41. As a result, the Board of Directors gave approval to amend the exercise price of 2,907,347 common share purchase warrants issued by way of our completed 2012 Private Placements, which included the July, August and October 2012 closings of 507,019, our June 2012 closing of 562,551 and the Baytree advisory agreement warrants of 1,837,777. The exercise price of the 2,907,347 common share purchase warrants was reduced to $0.27 from $0.41 per warrant share and applies to all warrants issued in our 2012 Private Placements. On April 2, 2014, the Company provided notice of adjustment to the Warrant Holders in accordance with the applicable section of the warrant certificate. The remaining terms, including expiration dates, of all warrants remain unchanged. The modified exercise price of the warrants to $0.27 resulted in a repricing modification charge of $98,000 that was recorded as a cost of capital raised in connection with the offering. For subsequent stock and warrant issuances including the debt conversion on June 11, 2014, the private placements in August and September, and the convertible credit line in September, the review of potential repricing of warrants resulted no further change from the exercise price of $0.27. | |||||||||||
Advisory Agreements | |||||||||||
Catalyst Global LLC. On October 14, 2013, the Company entered into a contract with Catalyst Global LLC (“CGL”), pursuant to which CGL agreed to provide investor relations services for 12 months in exchange for monthly fees of $2,000 per month and 450,000 shares of restricted common stock issued as follows: 180,000 shares upon signing and the balance vesting pro rata upon each of the three-, six-, and nine-month anniversaries of the contract. The initial tranche was valued at $0.05 per share or $9,000 when issued on November 8, 2013. During the three months ended September 30, 2014, we recorded expense of approximately $2,000. As of September 30, 2014, the total remaining balance of the prepaid investor relation services was approximately $1,000, and is included in other current assets and will be fully amortized by the end of the contract in October 2014. | |||||||||||
On March 19, 2014, the Company issued the second tranche shares valued at $ 0.38 per share, based on the price per share of the Company’s common stock. The costs associated with the 90,000 shares issued of $34,000 is being amortized over the remaining annual contract ending in October 2014. During the three months ended September 30, 2014, we recorded expense of approximately $17,000. As of September 30, 2014, the remaining balance of the prepaid investor relation services relating to the second tranche is $0. | |||||||||||
On April 23, 2014, the Company issued the third tranche shares valued at $ 0.30 per share, based on the price per share of the Company’s common stock. The costs associated with the 90,000 shares issued of $27,000 is being amortized over the remaining annual contract ending in October 2014. During the three months ended September 30, 2014, we recorded expense of approximately $14,000. As of September 30, 2014, the remaining balance of the prepaid investor relation services relating to the third tranche is $0. | |||||||||||
As of September 30, 2014, a liability was established to accrue for estimated costs of the fourth and final tranche that was issued on October 15, 2014, and was valued at $0.12 per share, based on the price per share of the Company’s common stock. The costs associated with the 90,000 shares issued of $10,800 will be fully expensed upon issuance, based on terms of the contract. | |||||||||||
Security Research Associates, Inc. On June 26, 2013, the Company entered into an agreement with Security Research Associates, Inc., (“SRA”), pursuant to which SRA agreed to provide business and advisory services. SRA served as our placement agent in connection with the Company’s 2014 Private Placement Offering (“Offering”) and was paid cash compensation in the amount of 9% of the gross proceeds raised and a warrant to purchase the number of shares of our common stock equal to 9% of the aggregate gross proceeds from the Offering received by the Company from all investors (excluding Esenjay) placed by SRA divided by $0.06 per share. SRA was paid $107,460 in cash and reimbursement for related expenses of approximately $10,000 and issued a warrant to purchase 1,791,000 shares of our common stock at an exercise price of $0.06 for its services as our private placement agent in the Offering. In connection with this agreement, the estimated fair value of the warrants issued in the approximate amount of $107,460 (1,791,000 warrants at $0.06) and related expenses of approximately $10,000 was recorded as an offset to equity related to expense associated with the Offering. The Company’s contract with SRA has been amended to reflect renewal to support the March 2014 placement and the recent August 2014 placement. In connection with the August 2014 placement, SRA earned a cash commission of $12,825 based on 9% of total gross proceeds raised and issued a warrant to purchase 142,500 shares of our common stock at an exercise price of $0.09 for its services as our private placement agent. The securities offered and sold have not been registered under the Securities Act. The securities were offered and sold in reliance upon exemptions from registration pursuant to Rule 506 promulgated thereunder. | |||||||||||
The Company has retained SRA on a best-efforts basis, as its placement agent for the placement of debt. The Company will pay to SRA for services rendered in conjunction with this debt financing in the amount of five percent (5%) of the gross proceeds raised and a warrant for the purchase of the Common Shares. The number Common Shares subject to the warrant will equal five percent (5%) of the aggregate gross proceeds from the Note received by the Company from the Lender divided by Twenty Cents ($0.20) per share. The warrant will have a term of three (3) years and will include cashless exercise provisions as well as representations and warranties that are customary and standard in warrants issued to placement agents or underwriters. The exercise price will equal twenty cents ($0.20). The Company also agrees to reimburse SRA periodically, upon request, or upon termination of SRA’s services, for SRA’s expenses incurred in connection with SRA’s financial advisory services, including fees and expenses of legal counsel, travel expenses and printing. All such non-accountable fees and expenses for the debt offering shall not exceed a combined aggregate amount of ten thousand dollars ($10,000). For the three months ended September 30, 2014 SRA earned $5,000 in cash commissions and 41,667 warrants with an estimated fair value of $3,000 based on loan proceeds on the Frenkel loan. As of November 14, 2014, SRA earned a cash commission of $9,500 at 5% of gross proceeds; and a right to exercise 79,167 warrants, exercisable into shares of common stock at $0.12 per share. | |||||||||||
Warrant Activity | |||||||||||
Warrant activity during the three months ended September 30, 2014 and related balances outstanding as of such dates are reflected below: | |||||||||||
Weighted | |||||||||||
Average | Remaining | ||||||||||
Exercise | Contract | ||||||||||
Price Per | Term (# | ||||||||||
Number | Share | years) | |||||||||
Shares purchasable under outstanding warrants at June 30, 2014 | 22,798,347 | $ | 0.21 | ||||||||
Stock purchase warrants issued | 1,809,167 | 0.14 | |||||||||
Stock purchase warrants exercised | - | - | |||||||||
Shares purchasable under outstanding warrants at September 30, 2014 | 24,607,514 | $ | 0.21 | 2.70 - 5.00 | |||||||
Warrant activity during the three months ended September 30, 2013 and related balances outstanding as of such dates are reflected below: | |||||||||||
Weighted | |||||||||||
Average | Remaining | ||||||||||
Exercise | Contract | ||||||||||
Price Per | Term (# | ||||||||||
Number | Share | years) | |||||||||
Shares purchasable under outstanding warrants at June 30, 2013 | 2,907,347 | $ | 0.41 | ||||||||
Stock purchase warrants issued | - | - | |||||||||
Stock purchase warrants exercised | - | - | |||||||||
Shares purchasable under outstanding warrants at September 30, 2013 | 2,907,347 | $ | 0.41 | 3.71 - 4.09 | |||||||
Stock-based Compensation | |||||||||||
During the three months ended September 30, 2014, the Company issued 400,000 non-qualified stock options of the Company’s common stock to a consultant, pursuant to a consulting agreement. These options were valued using the Black-Scholes model on the day they were originally due to be issued per agreement, and the Company recorded an accrual in the amount of $76,000 during the year ended June 30, 2014. Such options were issued in July 2014 when the current fair value of $64,000 was determined using the Black-Scholes model. The change in fair value of $12,000 was recorded as a reduction to stock based compensation expense during the period ended September 30, 2014. The Company has not registered the shares of common stock underlying stock options outstanding as of September 30, 2014. | |||||||||||
Activity in options during the three months ended September 30, 2014 and related balances outstanding as of that date are reflected below: | |||||||||||
Weighted | |||||||||||
Average | |||||||||||
Weighted | Remaining | ||||||||||
Number of | Average | Contract | |||||||||
Shares | Exercise Price | Term (# years) | |||||||||
Outstanding at June 30, 2014 | 6,335,695 | $ | 0.19 | ||||||||
Granted | 400,000 | ||||||||||
Exercised | - | ||||||||||
Forfeited and cancelled | - | ||||||||||
Outstanding at September 30, 2014 | 6,735,695 | $ | 0.18 | 7.47 | |||||||
Exercisable at September 30, 2014 | 4,246,573 | $ | 0.17 | 6.67 | |||||||
Activity in options during the three months ended September 30, 2013 and related balances outstanding as of that date are reflected below: | |||||||||||
Weighted | |||||||||||
Average | |||||||||||
Weighted | Remaining | ||||||||||
Number of | Average | Contract | |||||||||
Shares | Exercise Price | Term (# years) | |||||||||
Outstanding at June 30, 2013 | 2,527,389 | $ | 0.15 | ||||||||
Granted | 3,010,973 | ||||||||||
Exercised | — | ||||||||||
Forfeited and cancelled | — | ||||||||||
Outstanding at September 30, 2013 | 5,538,362 | $ | 0.12 | 8.23 | |||||||
Exercisable at September 30, 2013 | 3,635,462 | $ | 0.19 | 7.49 | |||||||
Stock-based compensation expense recognized in our condensed consolidated statements of operations for the three months ended September 30, 2014 and 2013 includes compensation expense for stock-based options and awards granted, based on the grant date fair value. For options and awards granted, expenses are amortized under the straight-line method over the expected vesting period. Stock-based compensation expense recognized in the condensed consolidated statements of operations has been reduced for estimated forfeitures of options that are subject to vesting. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. | |||||||||||
The closing price of our stock at September 30, 2014 was $0.11. As a result, the intrinsic value of the exercisable options at September 30, 2014 is $90,000. | |||||||||||
We allocated stock-based compensation expense included in the condensed consolidated statements of operations for employee option grants and non-employee option grants as follows: | |||||||||||
Three months ended September 30, | 2014 | 2013 | |||||||||
Research and development | $ | 3,000 | $ | -1,000 | |||||||
General and administration | 48,000 | 24,000 | |||||||||
Total stock-based compensation expense | $ | 51,000 | $ | 23,000 | |||||||
The Company uses the Black-Scholes valuation model to calculate the fair value of stock options. The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below: | |||||||||||
Three months ended September 30, | 2014 | 2013 | |||||||||
Expected volatility | 100% | 218% | |||||||||
Risk free interest rate | 0.96% | 1.4% to 1.7% | |||||||||
Forfeiture rate | 0% | 13% | |||||||||
Dividend yield | 0% | 0% | |||||||||
Expected term | 3 years | 3-5 years | |||||||||
During the three months ended September 30, 2014, options granted were fully vested on the grant date. Accordingly, a forfeiture rate was not factored into the expense calculation. On options that have vesting, the current forfeiture rate of 17% will be used. | |||||||||||
The remaining amount of unrecognized stock-based compensation expense at September 30, 2014 is approximately $355,000, which is expected to be recognized over the weighted average period of 1.8 years. | |||||||||||
WARRANT_DERIVATIVE_LIABILITY
WARRANT DERIVATIVE LIABILITY | 3 Months Ended | |||||||||||||
Sep. 30, 2014 | ||||||||||||||
Derivative Liabilities [Abstract] | ' | |||||||||||||
Warrant Derivative Liability | ' | |||||||||||||
NOTE 7 – WARRANT DERIVATIVE LIABILITY | ||||||||||||||
At September 30, 2014 there were 2,907,347 outstanding warrants classified as derivative liabilities due to exercise price re-set provisions included in the underlying warrant agreements. | ||||||||||||||
Warrants classified as derivative liabilities are recorded at their estimated fair values at the issuance date and are revalued at each subsequent reporting date. These warrants were determined to have an estimated fair value per share and aggregate value as of September 30, 2014 and an aggregate value as of June 30, 2014 as follows: | ||||||||||||||
Estimated | ||||||||||||||
Fair Value Per | Estimated | Estimated | ||||||||||||
Share $ | Total Fair Value in | Total Fair Value in | ||||||||||||
as of | Aggregate $ | Aggregate $ | ||||||||||||
September 30, | as of | as of | ||||||||||||
Issued Warrants | 2014 | 30-Sep-14 | 30-Jun-14 | |||||||||||
June 2012 Warrants | 562,551 | $ | 0.05 | $ | 26,000 | $ | 110,000 | |||||||
July 2012 Warrants | 338,013 | 0.05 | 16,000 | 67,000 | ||||||||||
August 2012 Warrants | 120,719 | 0.05 | 6,000 | 24,000 | ||||||||||
October 2012 Warrants | 48,287 | 0.05 | 2,000 | 10,000 | ||||||||||
Advisory Agreement Warrants | 1,837,777 | 0.05 | 83,000 | 360,000 | ||||||||||
Total | 2,907,347 | $ | 133,000 | $ | 571,000 | |||||||||
The change in aggregate estimated fair value of the warrants classified as derivative liabilities during the three months ended September 30, 2014 totaling $438,000 is recorded on the accompanying condensed consolidated statement operations as other income. | ||||||||||||||
FAIR_VALUE_MEASUREMENTS
FAIR VALUE MEASUREMENTS | 3 Months Ended | |||||||||||||
Sep. 30, 2014 | ||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||
FAIR VALUE MEASUREMENTS | ' | |||||||||||||
NOTE 8 – FAIR VALUE MEASUREMENTS | ||||||||||||||
We follow FASB ASC Topic No. 820, Fair Value Measurements and Disclosures (“ASC 820”) in connection with financial assets and liabilities measured at fair value on a recurring basis subsequent to initial recognition. | ||||||||||||||
ASC 820 requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following categories: | ||||||||||||||
Level 1: Quoted market prices in active markets for identical assets and liabilities. | ||||||||||||||
Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. | ||||||||||||||
Level 3: Unobservable inputs that are not corroborated by market data | ||||||||||||||
The hierarchy noted above requires us to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value. | ||||||||||||||
The fair value of our recorded derivative liabilities is determined based on unobservable inputs that are not corroborated by market data, which is a (Level 3) classification. We record derivative liabilities on our balance sheets at fair value with changes in fair value recorded in our condensed consolidated statements of operations. | ||||||||||||||
Following is a summary as of the reporting date of the fair values and applicable level within the fair value hierarchy of assets and liabilities measured at fair value on a recurring basis: | ||||||||||||||
Quoted Prices in | ||||||||||||||
Active Markets | Significant | |||||||||||||
for Identical | Significant Other | Unobservable | ||||||||||||
At September 30, 2014: | Assets | Observable Inputs | Inputs | |||||||||||
(Level 1) | (Level 2) | (Level 3) | ||||||||||||
Description: | ||||||||||||||
Warrant derivative liabilities | $ | - | $ | - | $ | 133,000 | ||||||||
Quoted Prices in | ||||||||||||||
Active Markets | Significant | |||||||||||||
for Identical | Significant Other | Unobservable | ||||||||||||
At June 30, 2014: | Assets | Observable Inputs | Inputs | |||||||||||
(Level 1) | (Level 2) | (Level 3) | ||||||||||||
Description: | ||||||||||||||
Warrant derivative liabilities | $ | - | $ | - | $ | 571,000 | ||||||||
The table below sets forth a summary of changes in the fair value of our (Level 3) financial instruments for the three months ended September 30, 2014: | ||||||||||||||
Estimated fair | Change in estimated | |||||||||||||
Balance at | value of new | fair value | Balance at | |||||||||||
June 30, | derivative | recognized in results | September 30, | |||||||||||
2014 | liabilities | of operations | 2014 | |||||||||||
Warrant derivative liabilities | $ | 571,000 | $ | - | $ | -438,000 | $ | 133,000 | ||||||
OTHER_RELATED_PARTY_TRANSACTIO
OTHER RELATED PARTY TRANSACTIONS | 3 Months Ended |
Sep. 30, 2014 | |
Related Party Transactions [Abstract] | ' |
OTHER RELATED PARTY TRANSACTIONS | ' |
NOTE 9 – OTHER RELATED PARTY TRANSACTIONS | |
Transactions with Epic Boats | |
Effective July 1, 2013, we relocated our principal office and manufacturing to the Epic Boats (an entity founded and controlled by Chris Anthony, our board member and former Chief Executive Officer) facility in Vista, California. We entered into a month-to-month sublease agreement for shared space with Epic Boats. | |
On March 1, 2014, the landlord terminated its lease with Epic Boats resulting in the termination of our previous sublease agreement with Epic Boats, and entered into a lease with Flux Power as lessee. On February 25, 2014, Flux power entered into a two-year sublease agreement to rent the property, at $12,130 per month, with an annual increase of 3%. The agreement provides for monthly payments of approximately 10% of the monthly rental payment. On March 26, 2014, Flux Power as the sub-lesser entered into a new sublease agreement with Epic Boats as the sub-lessee, whereas Epic Boats agrees to pay Flux Power 10% of facility costs on a month to month basis, for a period no longer than through the end of the two year lease agreement. We believe our facility at Vista, California provide adequate space for our current and projected needs. | |
The Company received $4,000 from Epic Boats during the three months ended September 30, 2014 and paid to Epic Boats $15,000 during the three months ended September 30, 2013 related to sublease rent expense and income. | |
On October 21, 2009, we entered into an agreement with Epic Boats where Epic Boats assigned and transferred to Flux Power the entire right, title, and interest into products, technology, intellectual property, inventions and all improvements thereof, for several product types. As of this date, Flux Power began selling products to Epic Boats under Flux Power's standard terms and conditions and has continued to sell products to Epic Boats as a customer. During the three months ended September 30, 2014 and 2013, Flux Power had $0 and $3,000 sales of product to Epic Boats, respectively. On April 7, 2014, the Company sold $3,000 worth of assets that were fully depreciated, with no anticipated use for the Company to Epic Boats. The customer deposits balance received from Epic Boats at September 30, 2014 and June 30, 2014 is approximately $136,000. There were no receivables outstanding from Epic Boats as of September 30, 2014 or June 30, 2014. | |
CONCENTRATIONS
CONCENTRATIONS | 3 Months Ended |
Sep. 30, 2014 | |
Risks and Uncertainties [Abstract] | ' |
CONCENTRATIONS | ' |
NOTE 10 – CONCENTRATIONS | |
Credit Risk | |
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of temporary cash investments. The Company maintains cash balances at a financial institution in San Diego, California. The Company’s cash balance at this institution is secured by the Federal Deposit Insurance Corporation. As of September 30, 2014, cash totaled approximately $58,000, which consists of funds held in a non-interest bearing bank deposit account. The Company has not experienced any losses in such accounts. Management believes that the Company is not exposed to any significant credit risk with respect to its cash. | |
Customer Concentrations | |
During the three months ended September 30, 2014, the Company had three customers that represented more than 10% of its revenues on an individual basis, and approximately $62,000 and 72%, in the aggregate. | |
During the three months ended September 30, 2013, the Company had five customers that represented more than 10% of its revenues on an individual basis, and approximately $28,000 and 80%, in the aggregate. | |
Suppliers/Vendor Concentrations | |
We obtain components and supplies included in our products from a small group of suppliers. During the three months ended September 30, 2014, we had four suppliers who accounted for more than 10% of our total inventory purchases on an individual basis and approximately 69% in the aggregate. | |
During the three months ended September 30, 2013, we had four suppliers who accounted for more than 10% of our total inventory purchases on an individual basis and approximately 77% in the aggregate. | |
In the past we have sourced Lithium batteries from a number of suppliers. We realign our battery sourcing periodically to improve consistency, responsiveness, and quality. | |
SUBSEQUENT_EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Sep. 30, 2014 | |
Subsequent Events [Abstract] | ' |
SUBSEQUENT EVENTS | ' |
NOTE 11 – SUBSEQUENT EVENTS | |
As discussed in Note 4, on October 2, 2014, the Company entered in a line of credit agreement in the maximum amount of $500,000 (“Second Line of Credit”) with Leon Frenkel (“Lender”). Borrowings under the Second Line of Credit bears interest at 8% per annum, with all unpaid principal and accrued interest due and payable on September 19, 2016 pursuant to the terms of the Secured Convertible Promissory Note (the “Note”). In addition, at the election of Lender, all or any portion of the outstanding principal, accrued but unpaid interest and/or late charges under the Second Line of Credit may be converted into shares of the Company’s common stock at any time at a conversion price of $0.12 per share. Borrowings under the Second Line of Credit are guaranteed by the Company and its wholly owned subsidiary, and are secured by all of the assets of the Company pursuant to the terms of a certain Security Agreement and Guaranty Agreement dated as of October 2, 2014. Proceeds from the Second Line of Credit can be solely used for working capital purposes. As of November 14, 2014, the Company has borrowed approximately $190,000 under the Second Line of Credit. In connection with the Second Line of Credit, Lender is entitled to purchase a certain number of shares of common stock of the Company equal to the outstanding advances under the Second Line of Credit divided by the conversion price of $0.12, for a term of five years, at an exercise price per share equal to $0.20. The Lender has no other material relationship with the Company or its affiliates. In connection services provided by SRA with the placement of the note, as of November 14, 2014, SRA earned a cash commission of $9,500 at 5% of gross proceeds; and 79,167 warrants, exercisable into shares of common stock at $0.12 per share. Additionally in connection with the draw of $190,000, Lender will be issued a warrant, pursuant to which he may exercise into 1,583,333 shares of common stock at $0.20 per share. | |
On October 15, 2014, we issued the fourth and final tranche of shares to Catalyst Global, LLC, valued at $ 0.12 per share, based on the price per share of the Company’s common stock. The costs associated with the 90,000 shares issued of $10,800 will be amortized upon issuance. | |
On October 17, 2014, we sold 2 units to one (1) accredited investor for total gross proceeds of $180,000, pursuant to which we issued 2,000,000 shares of common stocks and warrants to purchase up to 1,000,000 shares of common stock. The warrants are exercisable for three years and each warrant entitles the holder to purchase one share of common stock at $0.25 per share. The units were offered only to accredited investors and the purchase price of each unit was $90,000, with each unit consisting of 1,000,000 shares of common stock and 500,000 warrants. SRA served as our placement agent. SRA earned $16,000 as a commission at 9% of gross proceeds and issued a warrant to purchase 180,000 shares of our common stock at an exercise price of $0.09 for its services as our private placement agent. The securities offered and sold have not been registered under the Securities Act. The securities were offered and sold in reliance upon exemptions from registration pursuant to Rule 506 promulgated thereunder. | |
On October 24, 2014, we received and accepted Mr. James Gevarges resignation letter, dated October 10, 2014, from the board of directors of Flux Power Holdings, Inc. (the “Company”), effective October 24, 2014. Mr. Gevarges’s resignation was not the result of any disagreements with the Company on any matters relating to the Company’s operations, policies or practices. Mr. Gevarges indicated that he resigned for personal reasons. | |
On November 3, 2014, the Company announced formation of an Advisory Board of up to six members, and named Sir Nigel Burney and Steven Capelli as inaugural Advisory Board members. | |
SUMMARY_OF_SIGNIFICANT_ACCOUNT1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Sep. 30, 2014 | |
Accounting Policies [Abstract] | ' |
Basis of Consolidation | ' |
Basis of Consolidation | |
The condensed consolidated financial statements include the Flux Power Holdings, Inc. and its wholly-owned subsidiary Flux Power Inc. after elimination of all intercompany accounts and transactions. | |
Subsequent Events | ' |
Subsequent Events | |
Management has evaluated events subsequent to September 30, 2014 through the date filed with the Securities and Exchange Commission for transactions and other events that may require adjustment of and/or disclosure in such financial statements. | |
Reclassifications | ' |
Reclassifications | |
Certain prior year amounts have been reclassified to conform to the current year presentation for comparative purposes. | |
Use of Estimates in Financial Statement Preparation | ' |
Use of Estimates in Financial Statement Preparation | |
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as certain financial statement disclosures. Significant estimates include valuations of equity instruments and deferred tax assets. While management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from these estimates. | |
Cash and Cash Equivalents | ' |
Cash and Cash Equivalents | |
As of September 30, 2014, cash totaled approximately $58,000 and consists of funds held in a non-interest bearing bank deposit account. The Company considers all highly liquid short term investments with maturities of less than three months when acquired to be cash equivalents. The Company had no other cash equivalents at September 30, 2014 and June 30, 2014. | |
Fair Values of Financial Instruments | ' |
Fair Values of Financial Instruments | |
The carrying amount of our accounts payable and accounts receivable approximates their estimated fair values due to the short-term maturities of those financial instruments. The carrying amount of notes payable and line of credit approximates their fair value as the interest approximates current market interest rates for the similar instruments. Derivative liabilities recorded in connection with warrants are reported at their estimated fair value, with changes in fair value being reported in results of operations (see Note 8). Except for derivative liabilities referenced above, the Company does not have any other assets or liabilities that are measured at fair value on a nonrecurring basis. | |
Accounts Receivable and Customer Deposits | ' |
Accounts Receivable and Customer Deposits | |
Accounts receivable are carried at their estimated collectible amounts. The Company may require advance deposits from its customers prior to shipment of the ordered products. The Company has not experienced collection issues related to its accounts receivable, and has not recorded an allowance for doubtful accounts at either September 30, 2014 or June 30, 2014. | |
Inventories | ' |
Inventories | |
Inventories consist primarily of battery management systems and the related subcomponents, and are stated at the lower of cost (first-in, first-out) or market. The Company evaluates inventories to determine if write-downs are necessary due to obsolescence or if the inventory levels are in excess of anticipated demand at market value based on consideration of historical sales and product development plans. The Company did not record an adjustment related to obsolete inventory at either September 30, 2014 or June 30, 2014. | |
Property, Plant and Equipment | ' |
Property, Plant and Equipment | |
Property, plant and equipment are stated at cost, net of accumulated depreciation. Depreciation and amortization are provided using the straight-line method over the estimated useful lives, of the related assets ranging from three to ten years, or, in the case of leasehold improvements, over the lesser of the useful life of the related asset or the lease term. | |
Stock-based Compensation | ' |
Stock-based Compensation | |
Pursuant to the provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718-10, Compensation–Stock Compensation, which establishes accounting for equity instruments exchanged for employee service, we utilize the Black-Scholes option pricing model to estimate the fair value of employee stock option awards at the date of grant. This model, which requires the input of highly subjective assumptions, includes expected volatility and expected life of the options. Changes in these inputs and assumptions can materially affect the measure of estimated fair value of our share-based compensation. These assumptions are subjective and generally require significant analysis and judgment to develop. When estimating fair value, some of the assumptions will be based on, or determined from, external data and other assumptions may be derived from our historical experience with stock-based payment arrangements. The appropriate weight to place on historical experience is a matter of judgment, based on relevant facts and circumstances. In accordance with this guidance, the estimated grant-date fair value of options expected to vest is recognized as compensation expense on a pro-rata basis over the vesting period of the options. | |
Common stock or equity instruments such as warrants issued for services to non-employees are valued at their estimated fair value at the measurement date (the date when a firm commitment for performance of the services is reached, typically the date of issuance, or when performance is complete). | |
Revenue Recognition | ' |
Revenue Recognition | |
The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred, price is fixed or determinable, and collectability of the selling price is reasonably assured. Delivery occurs when risk of loss is passed to the customer, as specified by the terms of the applicable customer agreements. When a right of return exists, contractually or implied, the Company recognizes revenue on the sell-through method. Under this method, revenue is not recognized upon delivery of the inventory components. Instead, the Company records deferred revenue upon delivery and recognize revenue when the inventory components are sold through to the end user. During the three months ended September 30, 2014 and 2013, the Company did not record any deferred revenue. | |
Sales Returns and Allowances | ' |
Sales Returns and Allowances | |
The Company evaluates its exposure to sales returns and allowances based on historical experience. The Company has not experienced returns during the three months ended September 30, 2014 and 2013, and accordingly, the Company did not record sales returns and allowance. | |
Product Warranties | ' |
Product Warranties | |
The Company evaluates its exposure to product warranty obligations based on historical experience. Our products are warrantied for five years unless modified by a separate agreement. As of September 30, 2014 and June 30, 2014, the Company recorded warranty liability of approximately $12,000, which was included in accrued expenses on the Company’s balance sheet. | |
Shipping and Handling Costs | ' |
Shipping and Handling Costs | |
The Company records shipping and handling costs charged to customers as revenue and shipping and handling costs to cost of sales as incurred. | |
Impairment of Long-lived Assets | ' |
Impairment of Long-lived Assets | |
In accordance with authoritative guidance for the impairment or disposal of long-lived assets, if indicators of impairment exist, the Company assesses the recoverability of the affected long-lived assets by determining whether the carrying value of such assets can be recovered through the undiscounted future operating cash flows. | |
If impairment is indicated, the Company measures the amount of such impairment by comparing the carrying value of the asset to the present value of the expected future cash flows associated with the use of the asset. The Company believes that no impairment indicators are present. | |
Research and Development | ' |
Research and Development | |
The Company is actively engaged in new product development efforts. Research and development cost relating to possible future products are expensed as incurred. | |
Income Taxes | ' |
Income Taxes | |
The Company follows FASB ASC Topic No. 740, Income Taxes. Deferred tax assets or liabilities are recorded to reflect the future tax consequences of temporary differences between the financial reporting basis of assets and liabilities and their tax basis at each year-end. These amounts are adjusted, as appropriate, to reflect enacted changes in tax rates expected to be in effect when the temporary differences reverse. | |
The Company records deferred tax assets and liabilities based on the differences between the financial statement and tax bases of assets and liabilities and on operating loss carry forwards using enacted tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. | |
We also follow the provisions of FASB ASC Topic No.740 relating to uncertain tax provisions and have analyzed filing positions in all of the federal and state jurisdictions where the Company is required to file income tax returns, as well as all open tax years in these jurisdictions. Based on our analysis, no unrecognized tax benefits have been identified as of September 30, 2014 or June 30, 2014, and accordingly, no additional tax liabilities have been recorded. | |
Net Income (Loss) Per Common Share | ' |
Net Income (Loss) Per Common Share | |
The Company calculates basic income (loss) per common share by dividing net earnings or loss by the weighted average number of common shares outstanding during the periods. Diluted earnings (loss) per common share include the impact from all dilutive potential common shares relating to outstanding convertible securities. | |
For the three months, ended September 30, 2014, basic and diluted weighted-average common shares outstanding were 93,857,083. The Company incurred a net loss for the three months ended September 30, 2014, and therefore, basic and diluted loss per share for those periods are the same because the inclusion of potential common equivalent shares were excluded from diluted weighted-average common shares outstanding during the period, as the inclusion of such shares would be anti-dilutive. As of September 30, 2014, there were 2,625,992 potentially dilutive common shares outstanding, which include common shares underlying outstanding stock options and warrants that were excluded from diluted weighted-average common shares outstanding. | |
For the three months, ended September 30, 2013, basic and diluted weighted-average common shares outstanding were 47,493,619. The Company incurred a net loss for the three months ended September 30, 2013, and therefore, basic and diluted loss per share for those periods are the same because the inclusion of potential common equivalent shares were excluded from diluted weighted-average common shares outstanding during the period, as the inclusion of such shares would be anti-dilutive. As of September 30, 2013, there were 808,662 potentially dilutive common shares outstanding, which include common shares underlying outstanding stock options and warrants that were excluded from diluted weighted-average common shares outstanding. | |
Derivative Financial Instruments | ' |
Derivative Financial Instruments | |
The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. | |
We evaluate free-standing derivative instruments (or embedded derivatives) to properly classify such instruments within equity or as liabilities in our financial statements. The classification of a derivative instrument is reassessed at each reporting date. If the classification changes because of events during a reporting period, the instrument is reclassified as of the date of the event that caused the reclassification. There is no limit on the number of times a contract may be reclassified. | |
Instruments classified as derivative liabilities are recorded initially at their estimated fair value and are re-measured each reporting period (or upon reclassification) and the change in fair value is recorded on our condensed consolidated statements of operations in other (income) expense. | |
The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic No. 815, Derivatives and Hedging to classify and value warrant liabilities. Warrants classified as derivative liabilities are recorded at their fair values at the issuance date and are revalued at each subsequent reporting date, using a Monte Carlo simulation (“MCS”). A MCS model uses a simulation technique to generate multiple random price paths for the stock price to simulate many possible future outcomes, which are then discounted at the risk-free rate. These simulated paths are then averaged to determine the fair value of the warrants (see Note 7). | |
New Accounting Standards | ' |
New Accounting Standards | |
In August 2014, The FASB issued Accounting Standards Update (ASU) No. 2014-15 regarding ASC topic No. 205, Presentation of Financial Statements – Going Concern. The standard requires all companies to evaluate if conditions or events raise substantial doubt about an entity’s ability to continue as a going concern and requires different disclosure of items that raise substantial doubt bit are, or are not, alleviated as a result of consideration of management’s plans. ASU 2014-15 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2016. Early adoption is permitted. We are currently evaluating the impact this guidance will have on our consolidated financial statements. | |
STOCKHOLDERS_EQUITY_Tables
STOCKHOLDERS' EQUITY (Tables) | 3 Months Ended | ||||||||||
Sep. 30, 2014 | |||||||||||
Stockholders' Equity Note [Abstract] | ' | ||||||||||
Warrant Activity and Related Balances Outstanding | ' | ||||||||||
Warrant activity during the three months ended September 30, 2014 and related balances outstanding as of such dates are reflected below: | |||||||||||
Weighted | |||||||||||
Average | Remaining | ||||||||||
Exercise | Contract | ||||||||||
Price Per | Term (# | ||||||||||
Number | Share | years) | |||||||||
Shares purchasable under outstanding warrants at June 30, 2014 | 22,798,347 | $ | 0.21 | ||||||||
Stock purchase warrants issued | 1,809,167 | 0.14 | |||||||||
Stock purchase warrants exercised | - | - | |||||||||
Shares purchasable under outstanding warrants at September 30, 2014 | 24,607,514 | $ | 0.21 | 2.70 - 5.00 | |||||||
Warrant activity during the three months ended September 30, 2013 and related balances outstanding as of such dates are reflected below: | |||||||||||
Weighted | |||||||||||
Average | Remaining | ||||||||||
Exercise | Contract | ||||||||||
Price Per | Term (# | ||||||||||
Number | Share | years) | |||||||||
Shares purchasable under outstanding warrants at June 30, 2013 | 2,907,347 | $ | 0.41 | ||||||||
Stock purchase warrants issued | - | - | |||||||||
Stock purchase warrants exercised | - | - | |||||||||
Shares purchasable under outstanding warrants at September 30, 2013 | 2,907,347 | $ | 0.41 | 3.71 - 4.09 | |||||||
Stock Options Activity | ' | ||||||||||
Activity in options during the three months ended September 30, 2014 and related balances outstanding as of that date are reflected below: | |||||||||||
Weighted | |||||||||||
Average | |||||||||||
Weighted | Remaining | ||||||||||
Number of | Average | Contract | |||||||||
Shares | Exercise Price | Term (# years) | |||||||||
Outstanding at June 30, 2014 | 6,335,695 | $ | 0.19 | ||||||||
Granted | 400,000 | ||||||||||
Exercised | - | ||||||||||
Forfeited and cancelled | - | ||||||||||
Outstanding at September 30, 2014 | 6,735,695 | $ | 0.18 | 7.47 | |||||||
Exercisable at September 30, 2014 | 4,246,573 | $ | 0.17 | 6.67 | |||||||
Activity in options during the three months ended September 30, 2013 and related balances outstanding as of that date are reflected below: | |||||||||||
Weighted | |||||||||||
Average | |||||||||||
Weighted | Remaining | ||||||||||
Number of | Average | Contract | |||||||||
Shares | Exercise Price | Term (# years) | |||||||||
Outstanding at June 30, 2013 | 2,527,389 | $ | 0.15 | ||||||||
Granted | 3,010,973 | ||||||||||
Exercised | — | ||||||||||
Forfeited and cancelled | — | ||||||||||
Outstanding at September 30, 2013 | 5,538,362 | $ | 0.12 | 8.23 | |||||||
Exercisable at September 30, 2013 | 3,635,462 | $ | 0.19 | 7.49 | |||||||
Employee Option Grants and Non-employee Option Grants | ' | ||||||||||
We allocated stock-based compensation expense included in the condensed consolidated statements of operations for employee option grants and non-employee option grants as follows: | |||||||||||
Three months ended September 30, | 2014 | 2013 | |||||||||
Research and development | $ | 3,000 | $ | -1,000 | |||||||
General and administration | 48,000 | 24,000 | |||||||||
Total stock-based compensation expense | $ | 51,000 | $ | 23,000 | |||||||
Stock Options Valuation Assumptions | ' | ||||||||||
The Company uses the Black-Scholes valuation model to calculate the fair value of stock options. The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below: | |||||||||||
Three months ended September 30, | 2014 | 2013 | |||||||||
Expected volatility | 100% | 218% | |||||||||
Risk free interest rate | 0.96% | 1.4% to 1.7% | |||||||||
Forfeiture rate | 0% | 13% | |||||||||
Dividend yield | 0% | 0% | |||||||||
Expected term | 3 years | 3-5 years | |||||||||
WARRANT_DERIVATIVE_LIABILITY_T
WARRANT DERIVATIVE LIABILITY (Tables) | 3 Months Ended | |||||||||||||
Sep. 30, 2014 | ||||||||||||||
Derivative Liabilities [Abstract] | ' | |||||||||||||
Fair Value Measurements, Nonrecurring | ' | |||||||||||||
These warrants were determined to have an estimated fair value per share and aggregate value as of September 30, 2014 and an aggregate value as of June 30, 2014 as follows: | ||||||||||||||
Estimated | ||||||||||||||
Fair Value Per | Estimated | Estimated | ||||||||||||
Share $ | Total Fair Value in | Total Fair Value in | ||||||||||||
as of | Aggregate $ | Aggregate $ | ||||||||||||
September 30, | as of | as of | ||||||||||||
Issued Warrants | 2014 | 30-Sep-14 | 30-Jun-14 | |||||||||||
June 2012 Warrants | 562,551 | $ | 0.05 | $ | 26,000 | $ | 110,000 | |||||||
July 2012 Warrants | 338,013 | 0.05 | 16,000 | 67,000 | ||||||||||
August 2012 Warrants | 120,719 | 0.05 | 6,000 | 24,000 | ||||||||||
October 2012 Warrants | 48,287 | 0.05 | 2,000 | 10,000 | ||||||||||
Advisory Agreement Warrants | 1,837,777 | 0.05 | 83,000 | 360,000 | ||||||||||
Total | 2,907,347 | $ | 133,000 | $ | 571,000 | |||||||||
FAIR_VALUE_MEASUREMENTS_Tables
FAIR VALUE MEASUREMENTS (Tables) | 3 Months Ended | |||||||||||||
Sep. 30, 2014 | ||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | ' | |||||||||||||
Following is a summary as of the reporting date of the fair values and applicable level within the fair value hierarchy of assets and liabilities measured at fair value on a recurring basis: | ||||||||||||||
Quoted Prices in | ||||||||||||||
Active Markets | Significant | |||||||||||||
for Identical | Significant Other | Unobservable | ||||||||||||
At September 30, 2014: | Assets | Observable Inputs | Inputs | |||||||||||
(Level 1) | (Level 2) | (Level 3) | ||||||||||||
Description: | ||||||||||||||
Warrant derivative liabilities | $ | - | $ | - | $ | 133,000 | ||||||||
Quoted Prices in | ||||||||||||||
Active Markets | Significant | |||||||||||||
for Identical | Significant Other | Unobservable | ||||||||||||
At June 30, 2014: | Assets | Observable Inputs | Inputs | |||||||||||
(Level 1) | (Level 2) | (Level 3) | ||||||||||||
Description: | ||||||||||||||
Warrant derivative liabilities | $ | - | $ | - | $ | 571,000 | ||||||||
Fair Value Measurements | ' | |||||||||||||
The table below sets forth a summary of changes in the fair value of our (Level 3) financial instruments for the three months ended September 30, 2014: | ||||||||||||||
Estimated fair | Change in estimated | |||||||||||||
Balance at | value of new | fair value | Balance at | |||||||||||
June 30, | derivative | recognized in results | September 30, | |||||||||||
2014 | liabilities | of operations | 2014 | |||||||||||
Warrant derivative liabilities | $ | 571,000 | $ | - | $ | -438,000 | $ | 133,000 | ||||||
LIQUIDITIY_AND_GOING_CONCERN_A
LIQUIDITIY AND GOING CONCERN - Additional Information (Detail) (USD $) | 3 Months Ended | 0 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Jun. 30, 2014 | Nov. 14, 2014 | |
Subsequent Event [Member] | ||||
Private Placement 2014 [Member] | ||||
Going Concern [Line Items] | ' | ' | ' | ' |
Accumulated deficit | ($8,473,000) | ' | ($8,276,000) | ' |
Intend To Raise Private Placement Offering | ' | ' | ' | 990,000 |
Proceeds from Issuance of Private Placement | 129,000 | 0 | ' | 322,500 |
Additional Capital Required | $1,600,000 | ' | ' | ' |
Recovered_Sheet1
Summary of Significant Accounting Policies - Additional Information (Detail) (USD $) | 3 Months Ended | |||
Sep. 30, 2014 | Sep. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | |
Accounting Policies [Line Items] | ' | ' | ' | ' |
Cash and cash equivalents | $58,000 | $49,000 | $116,000 | $20,000 |
Product warranty liability | $12,000 | ' | $12,000 | ' |
Anti-dilutive options and warrants | 2,625,992 | 808,662 | ' | ' |
Weighted average number of common shares outstanding - basic | 93,857,083 | 47,493,619 | ' | ' |
RELATED_PARTY_NOTES_PAYABLE_AN1
RELATED PARTY NOTES PAYABLE AND LINE OF CREDIT - Additional Information (Detail) (USD $) | 0 Months Ended | 3 Months Ended | 3 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | 0 Months Ended | 0 Months Ended | 0 Months Ended | ||||||||||||||||||||||||||||||||||
Nov. 14, 2014 | Jun. 11, 2014 | Sep. 30, 2014 | Oct. 02, 2014 | Jun. 30, 2014 | Jan. 13, 2014 | Jun. 30, 2013 | Jun. 26, 2013 | Sep. 24, 2012 | Oct. 31, 2011 | Sep. 30, 2014 | Oct. 16, 2013 | Jun. 30, 2014 | Sep. 30, 2014 | Sep. 19, 2014 | Oct. 16, 2013 | Oct. 16, 2013 | Oct. 16, 2013 | Oct. 16, 2013 | Oct. 02, 2014 | Nov. 14, 2014 | Nov. 01, 2014 | Sep. 24, 2012 | Jun. 30, 2014 | Sep. 30, 2014 | Oct. 31, 2011 | Jun. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2013 | Mar. 07, 2012 | Oct. 16, 2013 | Oct. 16, 2013 | Aug. 21, 2014 | Nov. 13, 2014 | Oct. 02, 2014 | Nov. 14, 2014 | Jun. 11, 2014 | Mar. 12, 2014 | Jan. 13, 2014 | Mar. 12, 2014 | Jan. 13, 2014 | Mar. 12, 2014 | Jan. 13, 2014 | Oct. 31, 2011 | |
Warrant [Member] | Revolving promissory note Second Amendment [Member] | Line of Credit [Member] | Second Line of Credit [Member] | Second Line of Credit [Member] | Until December31, 2015 | First Amendment [Member] | First Amendment [Member] | First Amendment [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Revolving promissory note | Revolving promissory note | Revolving promissory note | Bridge Note [Member] | Bridge Note [Member] | Bridge Note [Member] | Bridge Note [Member] | Bridge Note [Member] | Bridge Note [Member] | Bridge Loan [Member] | Leon Frenkel [Member] | Leon Frenkel [Member] | Leon Frenkel [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | |||||||||||
Revolving promissory note Second Amendment [Member] | Until December31, 2013 | Until December31, 2015 | Second Amendment [Member] | First Amendment [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Unit [Member] | Unit [Member] | Secondary Revolving promissory note [Member] | Secondary Revolving promissory note [Member] | Major Stockholder [Member] | |||||||||||||||||||||||||||||||
Until December31, 2015 | ||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt instrument, principal amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $25,000 | ' | $250,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Equity Method Investment, Ownership Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 47.00% |
Debt instrument, interest rate, stated percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 6.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 8.00% | ' | ' | ' | 8.00% | 6.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Convertible, Conversion Price | ' | $0.27 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.30 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.30 | ' | ' | $0.12 | ' | $0.24 | ' | ' | ' | ' | ' | ' | ' |
Convertible Notes Payable, Noncurrent | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000,000 | ' | ' | ' | 250,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Line of Credit Facility, Maximum Borrowing Capacity | ' | ' | ' | ' | ' | ' | ' | ' | 1,500,000 | ' | ' | ' | ' | 50,000 | 50,000 | ' | 2,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 500,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Long-term Line of Credit | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 100,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25,000 | ' | 500,000 | 190,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Line of Credit Facility, Interest Rate at Period End | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 6.00% | ' | ' | ' | ' | ' | 8.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Line Of Credit Facility Conversion Maximum Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 400,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Line Of Credit Facility Convertible Conversion Price | ' | $0.24 | $0.12 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.06 | $0.30 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Units Issued During Period Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 150,000 | 600,000 | ' | ' | ' | ' | ' |
Unit Price | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $60,000 | $60,000 | ' | ' | ' | ' | ' |
Units Issued During Period Number | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2.5 | 10 | ' | ' | ' | ' | ' |
Proceeds From Issuance Of Units | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 200,000 | ' | ' | ' | ' | ' |
Debt Instrument, Decrease, Forgiveness | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 150,000 | 400,000 | ' |
Common Stock, Shares, Outstanding | ' | ' | 94,857,444 | ' | 93,274,113 | 1,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000,000 | 10,000,000 | ' | ' | ' |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | ' | ' | 2,907,347 | 190,000 | ' | 500,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 79,167 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,900,000 | 1,250,000 | ' | 500,000 | 5,000,000 | ' | ' | ' |
Stock Issued During Period, Shares, New Issues | 1,583,333 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,583,333 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,500,000 | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights | ' | ' | $0.20 | ' | ' | ' | $0.41 | $0.06 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.20 | $0.20 | $0.20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.20 | $0.30 | $0.20 | $0.20 | ' | ' | ' | ' | ' |
Debt Conversion, Original Debt, Amount | ' | 2,586,000 | 3,136,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Conversion Accrued Interest Original Debt Amount1 | ' | 304,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Conversion, Converted Instrument, Shares Issued | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 12,100,000 | ' | ' | ' | ' | ' | ' | ' |
Class Of Warrant Expiration Term | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | ' | ' | '3 years | ' | ' | ' | ' | ' | ' | ' |
Line of Credit Facility, Interest Rate During Period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 8.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Unused Borrowing Capacity, Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,225,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Unamortized Discount | ' | ' | 80,000 | ' | ' | ' | ' | ' | ' | ' | 40,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Convertible, Beneficial Conversion Feature | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $40,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
STOCKHOLDERS_EQUITY_Warrant_Ac
STOCKHOLDERS' EQUITY- Warrant Activity and Related Balances Outstanding (Detail) (USD $) | 3 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Number | ' | ' |
Shares purchasable under outstanding warrants at June 30, 2014 | 22,798,347 | 2,907,347 |
Stock purchase warrants issued | 1,809,167 | 0 |
Stock purchase warrants exercised | 0 | 0 |
Shares purchasable under outstanding warrants at September 30, 2014 | 24,607,514 | 2,907,347 |
Weighted Average Exercise Price Per Share | ' | ' |
Shares purchasable under outstanding warrants at June 30, 2014 | $0.21 | $0.41 |
Stock purchase warrants issued | $0.14 | $0 |
Stock purchase warrants exercised | $0 | $0 |
Shares purchasable under outstanding warrants at September 30, 2014 | $0.21 | $0.41 |
Maximum [Member] | ' | ' |
Remaining Contract Term | ' | ' |
Shares purchasable under outstanding warrants | '5 years | '4 years 1 month 2 days |
Minimum [Member] | ' | ' |
Remaining Contract Term | ' | ' |
Shares purchasable under outstanding warrants | '2 years 8 months 12 days | '3 years 8 months 16 days |
STOCKHOLDERS_EQUITY_Stock_Opti
STOCKHOLDERS' EQUITY - Stock Option Activity (Detail) (USD $) | 3 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Number of Shares | ' | ' |
Outstanding Begining | 6,335,695 | 2,527,389 |
Granted | 400,000 | 3,010,973 |
Exercised | 0 | 0 |
Forfeited and cancelled | 0 | 0 |
Outstanding Ending | 6,735,695 | 5,538,362 |
Exercisable | 4,246,573 | 3,635,462 |
Weighted Average Exercise Price Per Share | ' | ' |
Outstanding Begining | $0.19 | $0.15 |
Outstanding Ending | $0.18 | $0.12 |
Exercisable | $0.17 | $0.19 |
Weighted Average Remaining Contract Term (in years) | ' | ' |
Outstanding | '7 years 5 months 19 days | '8 years 2 months 23 days |
Exercisable | '6 years 8 months 1 day | '7 years 5 months 26 days |
STOCKHOLDERSs_EQUITY_Employee_
STOCKHOLDERS's EQUITY - Employee Option Grants and Non-employee Option Grants (Detail) (USD $) | 3 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Total stock-based compensation expense | $51,000 | $23,000 |
Research and Development Expense [Member] | ' | ' |
Total stock-based compensation expense | 3,000 | -1,000 |
General and Administrative Expense [Member] | ' | ' |
Total stock-based compensation expense | $48,000 | $24,000 |
STOCKHOLDERS_EQUITY_Assumption
STOCKHOLDERS' EQUITY - Assumptions Used to Measure Fair Value of Stock Options (Detail) | 3 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Share based Compensation Arrangement by Share based Payment Award, Fair Value Assumptions, Method Used [Line Items] | ' | ' |
Expected volatility | 100.00% | 218.00% |
Risk free interest rate, minimum | 0.96% | 1.40% |
Risk free interest rate, maximum | ' | 1.70% |
Forfeiture rate | 0.00% | 13.00% |
Dividend yield | 0.00% | 0.00% |
Expected term | '3 years | ' |
Minimum [Member] | ' | ' |
Share based Compensation Arrangement by Share based Payment Award, Fair Value Assumptions, Method Used [Line Items] | ' | ' |
Expected term | ' | '3 years |
Maximum [Member] | ' | ' |
Share based Compensation Arrangement by Share based Payment Award, Fair Value Assumptions, Method Used [Line Items] | ' | ' |
Expected term | ' | '5 years |
STOCKHOLDERS_EQUITY_Additional
STOCKHOLDERS' EQUITY- Additional Information (Detail) (USD $) | 0 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 0 Months Ended | 3 Months Ended | 1 Months Ended | 1 Months Ended | 0 Months Ended | 12 Months Ended | 1 Months Ended | 0 Months Ended | 3 Months Ended | 0 Months Ended | 1 Months Ended | 3 Months Ended | 1 Months Ended | 0 Months Ended | 3 Months Ended | 1 Months Ended | 0 Months Ended | 3 Months Ended | 1 Months Ended | 0 Months Ended | 1 Months Ended | 3 Months Ended | 1 Months Ended | ||||||||||||||||||||||||||||||||||||||||
Nov. 14, 2014 | Jun. 11, 2014 | Sep. 30, 2014 | Sep. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Oct. 02, 2014 | Jul. 31, 2014 | Jan. 13, 2014 | Jun. 26, 2013 | Oct. 31, 2011 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Jun. 11, 2014 | Mar. 12, 2014 | Mar. 31, 2014 | Jul. 31, 2014 | Jul. 31, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Apr. 23, 2014 | Mar. 19, 2014 | Feb. 14, 2014 | Jan. 13, 2014 | Mar. 12, 2014 | Jun. 11, 2014 | Jun. 30, 2013 | Feb. 14, 2014 | Mar. 12, 2014 | Oct. 14, 2013 | Sep. 30, 2014 | Sep. 30, 2014 | Apr. 23, 2014 | Nov. 08, 2013 | Dec. 18, 2013 | Jul. 31, 2014 | Sep. 30, 2014 | Mar. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Nov. 14, 2014 | Oct. 02, 2014 | Sep. 30, 2014 | Nov. 01, 2014 | Oct. 17, 2014 | Oct. 15, 2014 | Sep. 30, 2014 | Oct. 17, 2014 | Jun. 11, 2014 | Mar. 12, 2014 | Jan. 13, 2014 | Mar. 12, 2014 | Jun. 11, 2014 | Mar. 12, 2014 | Jan. 13, 2014 | Jun. 26, 2013 | Sep. 30, 2014 | Nov. 14, 2014 | Jul. 31, 2014 | Nov. 14, 2014 | Nov. 13, 2014 | Oct. 07, 2014 | Oct. 17, 2014 | |
July, August And October October 2012 Closing [Member] | Baytree advisory agreement [Member] | June 2012 Closing [Member] | 2012 Private Placement [Member] | 2012 Private Placement [Member] | 2012 Private Placement [Member] | 2014 Private Placement [Member] | 2014 Private Placement [Member] | 2015 Private Placement [Member] | 2015 Private Placement [Member] | Maximum [Member] | Minimum [Member] | Second Tranche [Member] | Second Tranche [Member] | Second Tranche [Member] | First Tranche [Member] | Final Tranche [Member] | Baytree Capital [Member] | Common Stock [Member] | Common Stock [Member] | Common Stock [Member] | Catalyst Global LLC [Member] | Catalyst Global LLC [Member] | Catalyst Global LLC [Member] | Catalyst Global LLC [Member] | Catalyst Global LLC [Member] | Institutional Analyst Holdings Inc [Member] | Accredited Investors [Member] | Frenkel loan [Member] | Unit [Member] | Shares Issued In Error [Member] | Shares Issued In Error [Member] | Each Unit [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Esenjay Investments LLC [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | ||||||||||||
Security Research Associates, Inc [Member] | 2012 Private Placement [Member] | 2012 Private Placement [Member] | Second Tranche [Member] | Final Tranche [Member] | Second Tranche [Member] | Second Tranche [Member] | First Tranche [Member] | First Tranche [Member] | 2015 Private Placement [Member] | Common Stock [Member] | Common Stock [Member] | 2014 Private Placement [Member] | 2015 Private Placement [Member] | Final Tranche [Member] | Final Tranche [Member] | Accredited Investors [Member] | Final Tranche [Member] | Unit [Member] | Unit [Member] | Unit [Member] | 2015 Private Placement [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | ||||||||||||||||||||||||||||||||||||||||||
2014 Private Placement [Member] | 2015 Private Placement [Member] | 2015 Private Placement [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders Equity Note Disclosure [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common stock, authorized | ' | ' | 145,000,000 | ' | 145,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common stock, par value | ' | ' | $0.00 | ' | $0.00 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred stock, authorized | ' | ' | 5,000,000 | ' | 5,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred stock, par value | ' | ' | $0.00 | ' | $0.00 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Warrant term | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Issuance or Sale of Equity | ' | ' | ' | ' | ' | $2,215,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Issuance Of Restricted Shares | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 450,000 | ' | ' | ' | 180,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Issuance Of Restricted Stock Price Per Share | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.05 | $0.06 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Issuance Of Restricted Shares Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Exercisable options intrinsic value | ' | ' | 90,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Sale of Stock, Price Per Share | ' | ' | $0.11 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Warrants issued | ' | ' | ' | ' | ' | 1,069,570 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common Stock Shares Issued | ' | ' | 94,857,444 | ' | 93,274,113 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 600,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common Stock Shares Outstanding | ' | ' | 94,857,444 | ' | 93,274,113 | ' | ' | ' | 1,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 600,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000,000 | 10,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Advisory Fees | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,000 | 2,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Units Issued During Period Number | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 32.4 | ' | 1.58 | ' | ' | ' | ' | ' | 2.8 | 10 | 19.6 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2 | ' | ' | ' | ' | 2.5 | 10 | 2.5 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Conversion, Converted Instrument, Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 550,000 | ' | ' | ' | ' | ' | ' | ' | ' | 400,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 12 | ' | ' | ' | ' | ' | ' | ' | ' | 150,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds From Issuance Of Units | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,394,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 200,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, New Issues | 1,583,333 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 32,400,000 | ' | 1,583,333 | ' | ' | ' | 90,000 | 90,000 | ' | 200,000 | ' | ' | 5,347,839 | 2,800,000 | 19,600,000 | ' | ' | ' | ' | ' | ' | 1,000,000 | ' | 1,000,000 | ' | 600,000 | ' | ' | 1,583,333 | ' | ' | 2,000,000 | 90,000 | 90,000 | 1,000,000 | ' | 2,500,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | ' | ' | 2,907,347 | ' | ' | ' | 190,000 | ' | 500,000 | ' | ' | 507,019 | 1,837,777 | 562,551 | ' | 2,907,347 | ' | 16,200,000 | ' | 791,667 | ' | ' | ' | ' | ' | 1,400,000 | ' | 9,800,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 500,000 | ' | ' | ' | ' | 500,000 | 79,167 | ' | ' | ' | 1,000,000 | ' | ' | 500,000 | 1,900,000 | 1,250,000 | ' | ' | ' | 500,000 | 5,000,000 | 1,791,000 | 1,791,000 | ' | 142,500 | 79,167 | ' | ' | 180,000 |
Investor Relation Services Prepaid Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000 | 0 | 14,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share Price | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.30 | $0.38 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.12 | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.06 | $0.06 | $0.12 | ' | ' | ' | ' | ' |
Payments of Stock Issuance Costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 27,000 | 34,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10,800 | 10,800 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Advisory Services Cash Compensation Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9.00% | 9.00% | ' | ' | ' | ' | ' | 9.00% |
Class Of Warrant Or Right Issued Or Issuable Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9.00% | 9.00% | ' | ' | ' | ' | ' | ' |
Payment For Advisory Services | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 12,825 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 107,460 | 107,460 | ' | ' | ' | ' | ' | 16,000 |
Warrants Not Settleable In Cash, Fair Value Disclosure | ' | ' | 133,000 | ' | 571,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 107,460 | ' | ' | ' | ' | ' | ' |
Purchase Price Of Each Unit | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $60,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $90,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $90,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Units Issued Aggregate Purchase Price | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 168,000 | 600,000 | 1,176,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 150,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Face Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 400,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class Of Warrants Or Rights Reprising Modification Charges | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 98,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Reimbursement For Related Expenses | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10,000 | ' | ' | ' | ' | ' | ' | ' |
Common stock initial exercise price | ' | ' | $0.20 | ' | ' | $0.41 | ' | ' | ' | $0.06 | ' | ' | ' | ' | ' | $0.41 | $0.27 | ' | $0.20 | $0.25 | ' | $0.41 | $0.27 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.20 | $0.20 | ' | $0.20 | $0.25 | ' | ' | ' | $0.30 | $0.20 | $0.20 | ' | ' | ' | ' | ' | $0.06 | ' | ' | ' | $0.09 | $0.09 | $0.09 |
Debt Conversion, Original Debt, Amount | ' | 2,586,000 | 3,136,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Conversion Accrued Interest Original Debt Amount1 | ' | 304,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Conversion, Converted Instrument, Shares Issued | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 12,100,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Convertible, Conversion Price | ' | $0.27 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.24 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock or Unit Option Plan Expense | ' | ' | 12,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Shares of common stock outstanding under the option plan | ' | ' | 6,735,695 | 5,538,362 | 6,335,695 | 2,527,389 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Intent To Raise Private Placement Offering | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 990,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Issuance of Private Placement | ' | ' | 129,000 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 142,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 180,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Commissions Received | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair Value Adjustment of Warrants | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10,300 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | ' | ' | ' | ' | ' | ' | ' | 64,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term | ' | ' | '1 year 9 months 18 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Dividends, Share-based Compensation, Stock | ' | ' | ' | ' | $76,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
WARRANT_DERIVATIVE_LIABILITY_F
WARRANT DERIVATIVE LIABILITY - Fair Value Per Share and Aggregate Value (Detail) (USD $) | Oct. 02, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Jan. 13, 2014 |
Accounting Policies [Line Items] | ' | ' | ' | ' |
Issued Warrants | 190,000 | 2,907,347 | ' | 500,000 |
Estimated Total Fair Value in Aggregate | ' | $133,000 | $571,000 | ' |
June 2012 Warrants [Member] | ' | ' | ' | ' |
Accounting Policies [Line Items] | ' | ' | ' | ' |
Issued Warrants | ' | 562,551 | ' | ' |
Estimated Fair Value Per Share | ' | $0.05 | ' | ' |
Estimated Total Fair Value in Aggregate | ' | 26,000 | 110,000 | ' |
July 2012 Warrants [Member] | ' | ' | ' | ' |
Accounting Policies [Line Items] | ' | ' | ' | ' |
Issued Warrants | ' | 338,013 | ' | ' |
Estimated Fair Value Per Share | ' | $0.05 | ' | ' |
Estimated Total Fair Value in Aggregate | ' | 16,000 | 67,000 | ' |
August 2012 Warrants [Member] | ' | ' | ' | ' |
Accounting Policies [Line Items] | ' | ' | ' | ' |
Issued Warrants | ' | 120,719 | ' | ' |
Estimated Fair Value Per Share | ' | $0.05 | ' | ' |
Estimated Total Fair Value in Aggregate | ' | 6,000 | 24,000 | ' |
October 2012 Warrants [Member] | ' | ' | ' | ' |
Accounting Policies [Line Items] | ' | ' | ' | ' |
Issued Warrants | ' | 48,287 | ' | ' |
Estimated Fair Value Per Share | ' | $0.05 | ' | ' |
Estimated Total Fair Value in Aggregate | ' | 2,000 | 10,000 | ' |
Advisory Agreement Warrants [Member] | ' | ' | ' | ' |
Accounting Policies [Line Items] | ' | ' | ' | ' |
Issued Warrants | ' | 1,837,777 | ' | ' |
Estimated Fair Value Per Share | ' | $0.05 | ' | ' |
Estimated Total Fair Value in Aggregate | ' | $83,000 | $360,000 | ' |
WARRANT_DERIVATIVE_LIABILITY_A
WARRANT DERIVATIVE LIABILITY - Additional Information (Detail) (USD $) | 3 Months Ended | |||
Sep. 30, 2014 | Sep. 30, 2013 | Oct. 02, 2014 | Jan. 13, 2014 | |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 2,907,347 | ' | 190,000 | 500,000 |
Gain Loss On Derivative Instruments Net Pretax | $438,000 | $81,000 | ' | ' |
FAIR_VALUE_MEASUREMENTS_Assets
FAIR VALUE MEASUREMENTS - Assets And Liabilities Measured At Fair Value On Recurring Basis (Detail) (USD $) | Sep. 30, 2014 | Jun. 30, 2014 |
Fair Value, Inputs, Level 1 | ' | ' |
Fair Value Measurements [Line Items] | ' | ' |
Warrant derivative liabilities | $0 | $0 |
Fair Value, Inputs, Level 2 | ' | ' |
Fair Value Measurements [Line Items] | ' | ' |
Warrant derivative liabilities | 0 | 0 |
Fair Value, Inputs, Level 3 | ' | ' |
Fair Value Measurements [Line Items] | ' | ' |
Warrant derivative liabilities | $133,000 | $571,000 |
FAIR_VALUE_MEASUREMENTS_Summar
FAIR VALUE MEASUREMENTS - Summary Of Changes In The Fair Value Of Level 3 Financial Instruments (Detail) (USD $) | 3 Months Ended |
Sep. 30, 2014 | |
Balance at the begining | $571,000 |
Change in fair value of warrant liability | 0 |
Warrant re-pricing modification charge (Note 7) | -438,000 |
Balance at the End | $133,000 |
OTHER_RELATED_PARTY_TRANSACTIO1
OTHER RELATED PARTY TRANSACTIONS - Additional Information (Detail) (USD $) | Sep. 30, 2014 | Jun. 30, 2014 | Apr. 07, 2014 | Mar. 26, 2014 | Feb. 25, 2014 | Sep. 30, 2014 | Sep. 30, 2013 |
Epic Boats Llc [Member] | Epic Boats Llc [Member] | Epic Boats Llc [Member] | Epic Boats Llc [Member] | Epic Boats Llc [Member] | |||
Operating Leases, Rent Expense | ' | ' | ' | ' | $12,130 | ' | $15,000 |
Percentage Of Annual Increase In Rental Of Sublease | ' | ' | ' | ' | 3.00% | ' | ' |
Percentage Of Monthly Rental Payment | ' | ' | ' | ' | 10.00% | ' | ' |
Percentage Of Facility Costs on Monthly Basis | ' | ' | ' | 10.00% | ' | ' | ' |
Operating Leases, Income Statement, Lease Revenue | ' | ' | ' | ' | ' | 4,000 | ' |
Related Party Deposit Liabilities | 136,000 | 136,000 | ' | ' | ' | ' | ' |
Sales Revenue, Goods, Net | ' | ' | ' | ' | ' | 0 | 3,000 |
Depreciation Expense on Reclassified Assets | ' | ' | $3,000 | ' | ' | ' | ' |
CONCENTRATIONS_Additional_Info
CONCENTRATIONS - Additional Information (Detail) (USD $) | 3 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Concentration Risk [Line Items] | ' | ' |
Cash, FDIC Insured Amount | $58,000 | ' |
Concentration Risk, Percentage | 10.00% | 10.00% |
Four Major Suppliers [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration Risk, Percentage | 10.00% | ' |
Percentage Of Purchases From Major Suppliers | 69.00% | ' |
Four Suppliers [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration Risk, Percentage | ' | 10.00% |
Percentage Of Purchases From Major Suppliers | ' | 77.00% |
Customer [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration Risk, Percentage | 72.00% | 80.00% |
Revenues | $62,000 | 28,000 |
SUBSEQUENT_EVENTS_Additional_I
SUBSEQUENT EVENTS - Additional Information (Detail) (USD $) | 0 Months Ended | 3 Months Ended | 0 Months Ended | 1 Months Ended | 0 Months Ended | 0 Months Ended | 3 Months Ended | 1 Months Ended | 0 Months Ended | 0 Months Ended | 1 Months Ended | 3 Months Ended | 0 Months Ended | 1 Months Ended | |||||||||||||||||||||
Nov. 14, 2014 | Sep. 30, 2014 | Sep. 30, 2013 | Oct. 02, 2014 | Jan. 13, 2014 | Jun. 30, 2013 | Jun. 26, 2013 | Mar. 12, 2014 | Mar. 12, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Jul. 31, 2014 | Jul. 31, 2014 | Nov. 13, 2014 | Nov. 14, 2014 | Oct. 02, 2014 | Nov. 01, 2014 | Oct. 15, 2014 | Sep. 30, 2014 | Oct. 17, 2014 | Oct. 17, 2014 | Aug. 21, 2014 | Nov. 13, 2014 | Oct. 02, 2014 | Nov. 14, 2014 | Oct. 07, 2014 | Nov. 14, 2014 | Jun. 26, 2013 | Sep. 30, 2014 | Jul. 31, 2014 | Nov. 14, 2014 | Nov. 14, 2014 | Nov. 13, 2014 | Oct. 07, 2014 | Oct. 17, 2014 | |
Final Tranche [Member] | 2014 Private Placement [Member] | 2014 Private Placement [Member] | 2014 Private Placement [Member] | 2015 Private Placement [Member] | 2015 Private Placement [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | Security Research Associates Inc [Member] | ||||||||
Each Unit [Member] | Accredited Investors [Member] | Final Tranche [Member] | Final Tranche [Member] | 2015 Private Placement [Member] | 2015 Private Placement [Member] | Bridge Loan [Member] | Leon Frenkel [Member] | Leon Frenkel [Member] | Leon Frenkel [Member] | Frenkel Line of Credit [Member] | 2015 Private Placement [Member] | Leon Frenkel [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | |||||||||||||||||||
Accredited Investors [Member] | 2015 Private Placement [Member] | ||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | ' | $0.20 | ' | ' | ' | $0.41 | $0.06 | ' | ' | $0.20 | ' | $0.25 | ' | ' | $0.20 | $0.20 | $0.20 | ' | ' | $0.25 | ' | ' | ' | ' | $0.20 | $0.20 | ' | ' | $0.06 | ' | ' | ' | $0.09 | $0.09 | $0.09 |
Long-term Line of Credit | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $25,000 | ' | $500,000 | $190,000 | ' | ' | ' | ' | ' | ' | $190,000 | ' | ' | ' |
Line of Credit Facility, Interest Rate During Period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 8.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Units Issued During Period Number | ' | ' | ' | ' | ' | ' | ' | 19.6 | 32.4 | ' | ' | 1.58 | ' | ' | ' | ' | ' | ' | ' | 2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Issuance of Private Placement | ' | 129,000 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | 142,500 | ' | ' | ' | ' | ' | ' | ' | 180,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, New Issues | 1,583,333 | ' | ' | ' | ' | ' | ' | ' | 32,400,000 | ' | ' | 1,583,333 | 1,000,000 | ' | ' | 1,583,333 | ' | 90,000 | 90,000 | 2,000,000 | 1,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | ' | 2,907,347 | ' | 190,000 | 500,000 | ' | ' | 9,800,000 | 16,200,000 | ' | 500,000 | 791,667 | 500,000 | ' | 79,167 | ' | ' | ' | ' | 1,000,000 | 500,000 | ' | ' | ' | ' | ' | ' | 1,791,000 | 1,791,000 | 142,500 | ' | 79,167 | ' | ' | 180,000 |
Purchase Price Of Each Unit | ' | ' | ' | ' | ' | ' | ' | ' | ' | $60,000 | ' | ' | $90,000 | ' | ' | ' | ' | ' | ' | ' | $90,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Payments of Stock Issuance Costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10,800 | 10,800 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Advisory Services Cash Compensation Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9.00% | 9.00% | ' | ' | ' | ' | ' | 9.00% |
Payment For Advisory Services | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 107,460 | 107,460 | ' | ' | ' | ' | ' | 16,000 |
Share Price | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.12 | ' | ' | ' | ' | ' | $0.12 | ' | ' | $0.12 | $0.06 | $0.06 | ' | ' | ' | ' | ' | ' |
Class Of Warrant Expiration Term | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '3 years | ' | ' | '5 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Commissions Received | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $9,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $9,500 | ' | ' | ' | ' |
Percentage Of Placement Agent Fee On Gross Proceeds Of Equity | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5.00% | ' | ' | ' | ' | ' | ' | ' | ' |